-
1
-
-
53849092394
-
In vitro biliary clearance of angiotensin II receptor blockers and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in sandwich-cultured rat hepatocytes: Comparison with in vivo biliary clearance
-
Abe K, Bridges AS, Yue W, and Brouwer KL (2008) In vitro biliary clearance of angiotensin II receptor blockers and 3-hydroxy-3-methylglutaryl- coenzyme A reductase inhibitors in sandwich-cultured rat hepatocytes: comparison with in vivo biliary clearance. J Pharmacol Exp Ther 326:983-990.
-
(2008)
J Pharmacol Exp Ther
, vol.326
, pp. 983-990
-
-
Abe, K.1
Bridges, A.S.2
Yue, W.3
Brouwer, K.L.4
-
2
-
-
0035478779
-
Predicting the impact of physiological and biochemical processes on oral drug bioavailability
-
Agoram B, Woltosz WS, and Bolger MB (2001) Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv Drug Deliv Rev 50 (Suppl 1):S41-S67.
-
(2001)
Adv Drug Deliv Rev
, vol.50
, Issue.SUPPL. 1
-
-
Agoram, B.1
Woltosz, W.S.2
Bolger, M.B.3
-
3
-
-
84865003528
-
A quantitative approach to hepatic clearance prediction of metabolism by aldehyde oxidase using custom pooled hepatocytes
-
Akabane T, Gerst N, Masters JN, and Tamura K (2012) A quantitative approach to hepatic clearance prediction of metabolism by aldehyde oxidase using custom pooled hepatocytes. Xenobiotica 42:863-871.
-
(2012)
Xenobiotica
, vol.42
, pp. 863-871
-
-
Akabane, T.1
Gerst, N.2
Masters, J.N.3
Tamura, K.4
-
4
-
-
68349150527
-
Towards a quantitative framework for the prediction of DDIs arising from cytochrome P450 induction
-
Almond LM, Yang J, Jamei M, Tucker GT, and Rostami-Hodjegan A (2009) Towards a quantitative framework for the prediction of DDIs arising from cytochrome P450 induction. Curr Drug Metab 10:420-432.
-
(2009)
Curr Drug Metab
, vol.10
, pp. 420-432
-
-
Almond, L.M.1
Yang, J.2
Jamei, M.3
Tucker, G.T.4
Rostami-Hodjegan, A.5
-
5
-
-
34548040152
-
High throughput solubility measurement in drug discovery and development
-
Alsenz J and Kansy M (2007) High throughput solubility measurement in drug discovery and development. Adv Drug Deliv Rev 59:546-567.
-
(2007)
Adv Drug Deliv Rev
, vol.59
, pp. 546-567
-
-
Alsenz, J.1
Kansy, M.2
-
6
-
-
34247552300
-
Development of a partially automated solubility screening (PASS) assay for early drug development
-
Alsenz J, Meister E, and Haenel E (2007) Development of a partially automated solubility screening (PASS) assay for early drug development. J Pharm Sci 96:1748-1762.
-
(2007)
J Pharm Sci
, vol.96
, pp. 1748-1762
-
-
Alsenz, J.1
Meister, E.2
Haenel, E.3
-
7
-
-
0028948839
-
A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
-
Amidon GL, Lennernäs H, Shah VP, and Crison JR (1995) A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413-420.
-
(1995)
Pharm Res
, vol.12
, pp. 413-420
-
-
Amidon, G.L.1
Lennernäs, H.2
Shah, V.P.3
Crison, J.R.4
-
8
-
-
0025311288
-
Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells
-
Artursson P (1990) Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J Pharm Sci 79:476-482.
-
(1990)
J Pharm Sci
, vol.79
, pp. 476-482
-
-
Artursson, P.1
-
9
-
-
0025804183
-
Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
-
Artursson P and Karlsson J (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 175:880-885.
-
(1991)
Biochem Biophys Res Commun
, vol.175
, pp. 880-885
-
-
Artursson, P.1
Karlsson, J.2
-
10
-
-
0025329248
-
Epithelial transport of drugs in cell culture. II: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells
-
Artursson P and Magnusson C (1990) Epithelial transport of drugs in cell culture. II: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells. J Pharm Sci 79:595-600.
-
(1990)
J Pharm Sci
, vol.79
, pp. 595-600
-
-
Artursson, P.1
Magnusson, C.2
-
11
-
-
0036891948
-
The influence of non-specific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties
-
Austin RP, Barton P, Cockroft SL, Wenlock MC, and Riley RJ (2002) The influence of non-specific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. Drug Metab Dispos 30:1497-1503.
-
(2002)
Drug Metab Dispos
, vol.30
, pp. 1497-1503
-
-
Austin, R.P.1
Barton, P.2
Cockroft, S.L.3
Wenlock, M.C.4
Riley, R.J.5
-
13
-
-
14144250264
-
Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method
-
Avdeef A, Artursson P, Neuhoff S, Lazorova L, Gråsjö J, and Tavelin S (2005) Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method. Eur J Pharm Sci 24:333-349.
-
(2005)
Eur J Pharm Sci
, vol.24
, pp. 333-349
-
-
Avdeef, A.1
Artursson, P.2
Neuhoff, S.3
Lazorova, L.4
Gråsjö, J.5
Tavelin, S.6
-
14
-
-
33845996187
-
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver
-
Barter ZE, Bayliss MK, Beaune PH, Boobis AR, Carlile DJ, Edwards RJ, Houston JB, Lake BG, Lipscomb JC, and Pelkonen OR, et al. (2007) Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. Curr Drug Metab 8:33-45.
-
(2007)
Curr Drug Metab
, vol.8
, pp. 33-45
-
-
Barter, Z.E.1
Bayliss, M.K.2
Beaune, P.H.3
Boobis, A.R.4
Carlile, D.J.5
Edwards, R.J.6
Houston, J.B.7
Lake, B.G.8
Lipscomb, J.C.9
Pelkonen, O.R.10
-
15
-
-
84888592045
-
Differences in cytochrome P450-mediated pharmacokinetics between Chinese and Caucasian populations predicted by mechanistic physiologically based pharmacokinetic modelling
-
DOI: [published ahead of print]
-
Barter ZE, Tucker GT, and Rowland-Yeo K (2013) Differences in cytochrome P450-mediated pharmacokinetics between Chinese and Caucasian populations predicted by mechanistic physiologically based pharmacokinetic modelling. Clin Pharmacokinet DOI: [published ahead of print].
-
(2013)
Clin Pharmacokinet
-
-
Barter, Z.E.1
Tucker, G.T.2
Rowland-Yeo, K.3
-
16
-
-
84875160515
-
Model-based approaches to predict drug-drug interactions associated with hepatic uptake transporters: Preclinical, clinical and beyond
-
Barton HA, Lai Y, Goosen TC, Jones HM, El-Kattan AF, Gosset JR, Lin J, and Varma MV (2013) Model-based approaches to predict drug-drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyond. Expert Opin Drug Metab Toxicol 9:459-472.
-
(2013)
Expert Opin Drug Metab Toxicol
, vol.9
, pp. 459-472
-
-
Barton, H.A.1
Lai, Y.2
Goosen, T.C.3
Jones, H.M.4
El-Kattan, A.F.5
Gosset, J.R.6
Lin, J.7
Varma, M.V.8
-
17
-
-
58449123081
-
Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research?
-
Beaumont K and Smith DA (2009) Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research? Curr Opin Drug Disc Dev 12:61-71.
-
(2009)
Curr Opin Drug Disc Dev
, vol.12
, pp. 61-71
-
-
Beaumont, K.1
Smith, D.A.2
-
18
-
-
67650714101
-
In silico prediction of volume of distribution in human using linear and nonlinear models on a 669 compound data set
-
Berellini G, Springer C, Waters NJ, and Lombardo F (2009) In silico prediction of volume of distribution in human using linear and nonlinear models on a 669 compound data set. J Med Chem 52:4488-4495.
-
(2009)
J Med Chem
, vol.52
, pp. 4488-4495
-
-
Berellini, G.1
Springer, C.2
Waters, N.J.3
Lombardo, F.4
-
19
-
-
2642536176
-
Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination
-
Berezhkovskiy LM (2004) Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination. J Pharm Sci 93:1628-1640.
-
(2004)
J Pharm Sci
, vol.93
, pp. 1628-1640
-
-
Berezhkovskiy, L.M.1
-
20
-
-
84862516296
-
On the accuracy of determination of unbound drug fraction in tissue using diluted tissue homogenate
-
Berezhkovskiy LM (2012) On the accuracy of determination of unbound drug fraction in tissue using diluted tissue homogenate. J Pharm Sci 101:1909-1916.
-
(2012)
J Pharm Sci
, vol.101
, pp. 1909-1916
-
-
Berezhkovskiy, L.M.1
-
21
-
-
33750192677
-
Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase
-
Bergman E, Forsell P, Tevell A, Persson EM, Hedeland M, Bondesson U, Knutson L, and Lennernäs H (2006) Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase. Eur J Pharm Sci 29:205-214.
-
(2006)
Eur J Pharm Sci
, vol.29
, pp. 205-214
-
-
Bergman, E.1
Forsell, P.2
Tevell, A.3
Persson, E.M.4
Hedeland, M.5
Bondesson, U.6
Knutson, L.7
Lennernäs, H.8
-
22
-
-
80054752374
-
Species differences in distribution and prediction of human V (ss) from preclinical data
-
Berry LM, Li C, and Zhao Z (2011) Species differences in distribution and prediction of human V (ss) from preclinical data. Drug Metab Dispos 39:2103-2116.
-
(2011)
Drug Metab Dispos
, vol.39
, pp. 2103-2116
-
-
Berry, L.M.1
Li, C.2
Zhao, Z.3
-
23
-
-
0034655372
-
A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates
-
Bevan CD and Lloyd RS (2000) A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. Anal Chem 72: 1781-1787.
-
(2000)
Anal Chem
, vol.72
, pp. 1781-1787
-
-
Bevan, C.D.1
Lloyd, R.S.2
-
24
-
-
33747841593
-
Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport
-
Bi YA, Kazolias D, and Duignan DB (2006) Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport. Drug Metab Dispos 34:1658-1665.
-
(2006)
Drug Metab Dispos
, vol.34
, pp. 1658-1665
-
-
Bi, Y.A.1
Kazolias, D.2
Duignan, D.B.3
-
25
-
-
84859908239
-
In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: Hepatocyte model optimization and retrospective investigation
-
Bi YA, Kimoto E, Sevidal S, Jones HM, Barton HA, Kempshall S, Whalen KM, Zhang H, Ji C, and Fenner KS, et al. (2012) In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: hepatocyte model optimization and retrospective investigation. Drug Metab Dispos 40:1085-1092.
-
(2012)
Drug Metab Dispos
, vol.40
, pp. 1085-1092
-
-
Bi, Y.A.1
Kimoto, E.2
Sevidal, S.3
Jones, H.M.4
Barton, H.A.5
Kempshall, S.6
Whalen, K.M.7
Zhang, H.8
Ji, C.9
Fenner, K.S.10
-
26
-
-
10744232330
-
The conduct of in vitro and in vivo drug-drug interaction studies: A Pharmaceutical Research and Manufacturers of America (PhRMA) perspective
-
Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Metabolism/Clinical Pharmacology Technical Working Group; ; FDA Center for Drug Evaluation and Research (CDER)
-
Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, and Ni L, et al.; Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Metabolism/Clinical Pharmacology Technical Working Group; ; FDA Center for Drug Evaluation and Research (CDER) (2003) The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. Drug Metab Dispos 31:815-832.
-
(2003)
Drug Metab Dispos
, vol.31
, pp. 815-832
-
-
Bjornsson, T.D.1
Callaghan, J.T.2
Einolf, H.J.3
Fischer, V.4
Gan, L.5
Grimm, S.6
Kao, J.7
King, S.P.8
Miwa, G.9
Ni, L.10
-
27
-
-
84877870763
-
Optimizing the in vitro and clinical assessment of drug interaction risk by understanding co-medications in patient populations
-
Bloomer J, Derimanov G, Dumont E, Ellens H, and Matheny C (2013) Optimizing the in vitro and clinical assessment of drug interaction risk by understanding co-medications in patient populations. Expert Opin Drug Metab Toxicol 9:737-751.
-
(2013)
Expert Opin Drug Metab Toxicol
, vol.9
, pp. 737-751
-
-
Bloomer, J.1
Derimanov, G.2
Dumont, E.3
Ellens, H.4
Matheny, C.5
-
28
-
-
0019974098
-
Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics
-
Boxenbaum H (1982) Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J Pharmacokinet Biopharm 10:201-227.
-
(1982)
J Pharmacokinet Biopharm
, vol.10
, pp. 201-227
-
-
Boxenbaum, H.1
-
29
-
-
3042575812
-
Allometric scaling of pharmacokinetic parameters in drug discovery: Can human CL, Vss and t1/2 be predicted from in-vivo rat data?
-
Caldwell GW, Masucci JA, Yan Z, and Hageman W (2004) Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data? Eur J Drug Metab Pharmacokinet 29:133-143.
-
(2004)
Eur J Drug Metab Pharmacokinet
, vol.29
, pp. 133-143
-
-
Caldwell, G.W.1
Masucci, J.A.2
Yan, Z.3
Hageman, W.4
-
30
-
-
33746903600
-
Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model
-
Cao X, Gibbs ST, Fang L, Miller HA, Landowski CP, Shin HC, Lennernas H, Zhong Y, Amidon GL, and Yu LX, et al. (2006) Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharm Res 23:1675-1686.
-
(2006)
Pharm Res
, vol.23
, pp. 1675-1686
-
-
Cao, X.1
Gibbs, S.T.2
Fang, L.3
Miller, H.A.4
Landowski, C.P.5
Shin, H.C.6
Lennernas, H.7
Zhong, Y.8
Amidon, G.L.9
Yu, L.X.10
-
32
-
-
3542995726
-
The complexities of hepatic drug transport: Current knowledge and emerging concepts
-
Chandra P and Brouwer KL (2004) The complexities of hepatic drug transport: current knowledge and emerging concepts. Pharm Res 21:719-735.
-
(2004)
Pharm Res
, vol.21
, pp. 719-735
-
-
Chandra, P.1
Brouwer, K.L.2
-
33
-
-
84862777396
-
Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: Strategy and approach during the drug discovery phase with four case studies
-
Chen Y, Jin JY, Mukadam S, Malhi V, and Kenny JR (2012) Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies. Biopharm Drug Dispos 33:85-98.
-
(2012)
Biopharm Drug Dispos
, vol.33
, pp. 85-98
-
-
Chen, Y.1
Jin, J.Y.2
Mukadam, S.3
Malhi, V.4
Kenny, J.R.5
-
34
-
-
79951930597
-
Utility of intersystem extrapolation factors in early reaction phenotyping and the quantitative extrapolation of human liver microsomal intrinsic clearance using recombinant cytochromes P450
-
Chen Y, Liu L, Nguyen K, and Fretland AJ (2011) Utility of intersystem extrapolation factors in early reaction phenotyping and the quantitative extrapolation of human liver microsomal intrinsic clearance using recombinant cytochromes P450. Drug Metab Dispos 39:373-382.
-
(2011)
Drug Metab Dispos
, vol.39
, pp. 373-382
-
-
Chen, Y.1
Liu, L.2
Nguyen, K.3
Fretland, A.J.4
-
35
-
-
68249152290
-
Prediction of hepatic clearance in human from in vitro data for successful drug development
-
Chiba M, Ishii Y, and Sugiyama Y (2009) Prediction of hepatic clearance in human from in vitro data for successful drug development. AAPS J 11:262-276.
-
(2009)
AAPS J
, vol.11
, pp. 262-276
-
-
Chiba, M.1
Ishii, Y.2
Sugiyama, Y.3
-
36
-
-
0031786518
-
Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats
-
Chiou WL and Barve A (1998) Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats. Pharm Res 15:1792-1795.
-
(1998)
Pharm Res
, vol.15
, pp. 1792-1795
-
-
Chiou, W.L.1
Barve, A.2
-
37
-
-
0036296060
-
Comparison of oral absorption and bioavailablity of drugs between monkey and human
-
Chiou WL and Buehler PW (2002) Comparison of oral absorption and bioavailablity of drugs between monkey and human. Pharm Res 19:868-874.
-
(2002)
Pharm Res
, vol.19
, pp. 868-874
-
-
Chiou, W.L.1
Buehler, P.W.2
-
38
-
-
0034017007
-
Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans
-
Chiou WL, Jeong HY, Chung SM, and Wu TC (2000) Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans. Pharm Res 17: 135-140.
-
(2000)
Pharm Res
, vol.17
, pp. 135-140
-
-
Chiou, W.L.1
Jeong, H.Y.2
Chung, S.M.3
Wu, T.C.4
-
39
-
-
67649404709
-
In vitro and in vivo induction of cytochrome p450: A survey of the current practices and recommendations: A pharmaceutical research and manufacturers of america perspective
-
Chu V, Einolf HJ, Evers R, Kumar G, Moore D, Ripp S, Silva J, Sinha V, Sinz M, and Skerjanec A (2009) In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a pharmaceutical research and manufacturers of america perspective. Drug Metab Dispos 37:1339-1354.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 1339-1354
-
-
Chu, V.1
Einolf, H.J.2
Evers, R.3
Kumar, G.4
Moore, D.5
Ripp, S.6
Silva, J.7
Sinha, V.8
Sinz, M.9
Skerjanec, A.10
-
40
-
-
0033984905
-
A new physiologically based, segregated-flow model to explain route-dependent intestinal metabolism
-
Cong D, Doherty M, and Pang KS (2000) A new physiologically based, segregated-flow model to explain route-dependent intestinal metabolism. Drug Metab Dispos 28:224-235.
-
(2000)
Drug Metab Dispos
, vol.28
, pp. 224-235
-
-
Cong, D.1
Doherty, M.2
Pang, K.S.3
-
41
-
-
79955023850
-
Prediction of human drug clearance by multiple metabolic pathways: Integration of hepatic and intestinal microsomal and cytosolic data
-
Cubitt HE, Houston JB, and Galetin A (2011) Prediction of human drug clearance by multiple metabolic pathways: integration of hepatic and intestinal microsomal and cytosolic data. Drug Metab Dispos 39:864-873.
-
(2011)
Drug Metab Dispos
, vol.39
, pp. 864-873
-
-
Cubitt, H.E.1
Houston, J.B.2
Galetin, A.3
-
42
-
-
79851476433
-
Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: A simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model
-
Darwich AS, Neuhoff S, Jamei M, and Rostami-Hodjegan A (2010) Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model. Curr Drug Metab 11:716-729.
-
(2010)
Curr Drug Metab
, vol.11
, pp. 716-729
-
-
Darwich, A.S.1
Neuhoff, S.2
Jamei, M.3
Rostami-Hodjegan, A.4
-
44
-
-
84870055979
-
Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design
-
Di L, Keefer C, Scott DO, Strelevitz TJ, Chang G, Bi YA, Lai Y, Duckworth J, Fenner K, and Troutman MD, et al. (2012a) Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design. Eur J Med Chem 57:441-448.
-
(2012)
Eur J Med Chem
, vol.57
, pp. 441-448
-
-
Di, L.1
Keefer, C.2
Scott, D.O.3
Strelevitz, T.J.4
Chang, G.5
Bi, Y.A.6
Lai, Y.7
Duckworth, J.8
Fenner, K.9
Troutman, M.D.10
-
45
-
-
84865156541
-
A novel relay method for determining low-clearance values
-
Di L, Trapa P, Obach RS, Atkinson K, Bi Y-A, Wolford AC, Tan B, McDonald TS, Lai Y, and Tremaine LM (2012b) A novel relay method for determining low-clearance values. Drug Metab Dispos 40:1860-1865.
-
(2012)
Drug Metab Dispos
, vol.40
, pp. 1860-1865
-
-
Di, L.1
Trapa, P.2
Obach, R.S.3
Atkinson, K.4
Bi, Y.-A.5
Wolford, A.C.6
Tan, B.7
McDonald, T.S.8
Lai, Y.9
Tremaine, L.M.10
-
46
-
-
80053250836
-
Development of a new permeability assay using low-efflux MDCKII cells
-
Di L, Whitney-Pickett C, Umland JP, Zhang H, Zhang X, Gebhard DF, Lai Y, Federico JJ, 3rd, Davidson RE, and Smith R, et al. (2011) Development of a new permeability assay using low-efflux MDCKII cells. J Pharm Sci 100:4974-4985.
-
(2011)
J Pharm Sci
, vol.100
, pp. 4974-4985
-
-
Di, L.1
Whitney-Pickett, C.2
Umland, J.P.3
Zhang, H.4
Zhang, X.5
Gebhard, D.F.6
Lai, Y.7
Federico III, J.J.8
Davidson, R.E.9
Smith, R.10
-
47
-
-
84873019348
-
Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information
-
Dumont C, Mentré F, Gaynor C, Brendel K, Gesson C, and Chenel M (2013) Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information. Clin Pharmacokinet 52:43-57.
-
(2013)
Clin Pharmacokinet
, vol.52
, pp. 43-57
-
-
Dumont, C.1
Mentré, F.2
Gaynor, C.3
Brendel, K.4
Gesson, C.5
Chenel, M.6
-
48
-
-
35648968125
-
Comparison of different approaches to predict metabolic drug-drug interactions
-
Einolf HJ (2007) Comparison of different approaches to predict metabolic drug-drug interactions. Xenobiotica 37:1257-1294.
-
(2007)
Xenobiotica
, vol.37
, pp. 1257-1294
-
-
Einolf, H.J.1
-
49
-
-
84867873811
-
Understanding the critical disposition pathways of statins to assess drug-drug interaction risk during drug development: It's not just about OATP1B1
-
Elsby R, Hilgendorf C, and Fenner K (2012) Understanding the critical disposition pathways of statins to assess drug-drug interaction risk during drug development: it's not just about OATP1B1. Clin Pharmacol Ther 92:584-598.
-
(2012)
Clin Pharmacol Ther
, vol.92
, pp. 584-598
-
-
Elsby, R.1
Hilgendorf, C.2
Fenner, K.3
-
51
-
-
79952343050
-
Methodologies for investigating drug metabolism at the early drug discovery stage: Prediction of hepatic drug clearance and P450 contribution
-
Emoto C, Murayama N, Rostami-Hodjegan A, and Yamazaki H (2010) Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution. Curr Drug Metab 11:678-685.
-
(2010)
Curr Drug Metab
, vol.11
, pp. 678-685
-
-
Emoto, C.1
Murayama, N.2
Rostami-Hodjegan, A.3
Yamazaki, H.4
-
52
-
-
0029855969
-
Comparison between permeability coefficients in rat and human jejunum
-
Fagerholm U, Johansson M, and Lennernäs H (1996) Comparison between permeability coefficients in rat and human jejunum. Pharm Res 13:1336-1342.
-
(1996)
Pharm Res
, vol.13
, pp. 1336-1342
-
-
Fagerholm, U.1
Johansson, M.2
Lennernäs, H.3
-
53
-
-
67650825002
-
Comparison of different algorithms for predicting clinical drug-drug interactions, based on the use of CYP3A4 in vitro data: Predictions of compounds as precipitants of interaction
-
Fahmi OA, Hurst S, Plowchalk D, Cook J, Guo F, Youdim K, Dickins M, Phipps A, Darekar A, and Hyland R, et al. (2009) Comparison of different algorithms for predicting clinical drug-drug interactions, based on the use of CYP3A4 in vitro data: predictions of compounds as precipitants of interaction. Drug Metab Dispos 37:1658-1666.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 1658-1666
-
-
Fahmi, O.A.1
Hurst, S.2
Plowchalk, D.3
Cook, J.4
Guo, F.5
Youdim, K.6
Dickins, M.7
Phipps, A.8
Darekar, A.9
Hyland, R.10
-
54
-
-
77955999532
-
Cytochrome P450 3A4 mRNA is a more reliable marker than CYP3A4 activity for detecting pregnane X receptor-activated induction of drug-metabolizing enzymes
-
Fahmi OA, Kish M, Boldt S, and Obach RS (2010) Cytochrome P450 3A4 mRNA is a more reliable marker than CYP3A4 activity for detecting pregnane X receptor-activated induction of drug-metabolizing enzymes. Drug Metab Dispos 38:1605-1611.
-
(2010)
Drug Metab Dispos
, vol.38
, pp. 1605-1611
-
-
Fahmi, O.A.1
Kish, M.2
Boldt, S.3
Obach, R.S.4
-
55
-
-
47949115175
-
A combined model for predicting CYP3A4 clinical net drug-drug interaction based on CYP3A4 inhibition, inactivation, and induction determined in vitro
-
Fahmi OA, Maurer TS, Kish M, Cardenas E, Boldt S, and Nettleton D (2008) A combined model for predicting CYP3A4 clinical net drug-drug interaction based on CYP3A4 inhibition, inactivation, and induction determined in vitro. Drug Metab Dispos 36:1698-1708.
-
(2008)
Drug Metab Dispos
, vol.36
, pp. 1698-1708
-
-
Fahmi, O.A.1
Maurer, T.S.2
Kish, M.3
Cardenas, E.4
Boldt, S.5
Nettleton, D.6
-
56
-
-
77958498196
-
Evaluation of models for predicting drug-drug interactions due to induction
-
Fahmi OA and Ripp SL (2010) Evaluation of models for predicting drug-drug interactions due to induction. Expert Opin Drug Metab Toxicol 6:1399-1416.
-
(2010)
Expert Opin Drug Metab Toxicol
, vol.6
, pp. 1399-1416
-
-
Fahmi, O.A.1
Ripp, S.L.2
-
57
-
-
79951500920
-
PBPK modeling of intestinal and liver enzymes and transporters in drug absorption and sequential metabolism
-
Fan J, Chen S, Chow EC, and Pang KS (2010) PBPK modeling of intestinal and liver enzymes and transporters in drug absorption and sequential metabolism. Curr Drug Metab 11:743-761.
-
(2010)
Curr Drug Metab
, vol.11
, pp. 743-761
-
-
Fan, J.1
Chen, S.2
Chow, E.C.3
Pang, K.S.4
-
59
-
-
58549088199
-
Drug-drug interactions mediated through P-glycoprotein: Clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug
-
Fenner KS, Troutman MD, Kempshall S, Cook JA, Ware JA, Smith DA, and Lee CA (2009) Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug. Clin Pharmacol Ther 85:173-181.
-
(2009)
Clin Pharmacol Ther
, vol.85
, pp. 173-181
-
-
Fenner, K.S.1
Troutman, M.D.2
Kempshall, S.3
Cook, J.A.4
Ware, J.A.5
Smith, D.A.6
Lee, C.A.7
-
60
-
-
46449095993
-
Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes
-
Fukuda H, Ohashi R, Tsuda-Tsukimoto M, and Tamai I (2008) Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes. Drug Metab Dispos 36:1275-1282.
-
(2008)
Drug Metab Dispos
, vol.36
, pp. 1275-1282
-
-
Fukuda, H.1
Ohashi, R.2
Tsuda-Tsukimoto, M.3
Tamai, I.4
-
61
-
-
84878824845
-
Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters: Application of PBPK modeling in the assessment of drug-drug interaction potential
-
Gertz M, Cartwright CM, Hobbs MJ, Kenworthy KE, Rowland M, Houston JB, and Galetin A (2013) Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters: application of PBPK modeling in the assessment of drug-drug interaction potential. Pharm Res 30:761-780.
-
(2013)
Pharm Res
, vol.30
, pp. 761-780
-
-
Gertz, M.1
Cartwright, C.M.2
Hobbs, M.J.3
Kenworthy, K.E.4
Rowland, M.5
Houston, J.B.6
Galetin, A.7
-
62
-
-
77953737073
-
Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data
-
Gertz M, Harrison A, Houston JB, and Galetin A (2010) Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data. Drug Metab Dispos 38:1147-1158.
-
(2010)
Drug Metab Dispos
, vol.38
, pp. 1147-1158
-
-
Gertz, M.1
Harrison, A.2
Houston, J.B.3
Galetin, A.4
-
63
-
-
1642306443
-
Quantitative structure-pharmacokinetic relationship modelling: Apparent volume of distribution
-
Ghafourian T, Barzegar-Jalali M, Hakimiha N, and Cronin MTD (2004) Quantitative structure-pharmacokinetic relationship modelling: apparent volume of distribution. J Pharm Pharmacol 56:339-350.
-
(2004)
J Pharm Pharmacol
, vol.56
, pp. 339-350
-
-
Ghafourian, T.1
Barzegar-Jalali, M.2
Hakimiha, N.3
Cronin, M.T.D.4
-
64
-
-
33646664459
-
A novel method for the determination of biliary clearance in humans
-
Ghibellini G, Johnson BM, Kowalsky RJ, Heizer WD, and Brouwer KL (2004) A novel method for the determination of biliary clearance in humans. AAPS J 6:e33.
-
(2004)
AAPS J
, vol.6
-
-
Ghibellini, G.1
Johnson, B.M.2
Kowalsky, R.J.3
Heizer, W.D.4
Brouwer, K.L.5
-
65
-
-
33847370159
-
In vitro in vivo correlation of hepatobiliary drug clearance in human
-
Ghibellini G, Vasist LS, Leslie EM, Heizer WD, Kowalsky RJ, Calvo BF, and Brouwer KLR (2007) In vitro in vivo correlation of hepatobiliary drug clearance in human. Clin Pharmacol Ther 81:406-413.
-
(2007)
Clin Pharmacol Ther
, vol.81
, pp. 406-413
-
-
Ghibellini, G.1
Vasist, L.S.2
Leslie, E.M.3
Heizer, W.D.4
Kowalsky, R.J.5
Calvo, B.F.6
Brouwer, K.L.R.7
-
66
-
-
77649216536
-
Membrane transporters in drug development
-
International Transporter Consortium
-
Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, and Hillgren KM, et al.; International Transporter Consortium (2010) Membrane transporters in drug development. Nat Rev Drug Discov 9:215-236.
-
(2010)
Nat Rev Drug Discov
, vol.9
, pp. 215-236
-
-
Giacomini, K.M.1
Huang, S.M.2
Tweedie, D.J.3
Benet, L.Z.4
Brouwer, K.L.5
Chu, X.6
Dahlin, A.7
Evers, R.8
Fischer, V.9
Hillgren, K.M.10
-
67
-
-
84887231773
-
Using human recombinant UDP-glucuronosyltransferase isoforms and a relative activity factor approach to model total body clearance of laropiprant (MK-0524) in humans
-
DOI: 10.3109/00498254.2013.791761 [published ahead of print]
-
Gibson CR, Lu P, Maciolek C, Wudarski C, Barter Z, Rowland-Yeo K, Stroh M, Lai E, and Nicoll-Griffith DA (2013) Using human recombinant UDP-glucuronosyltransferase isoforms and a relative activity factor approach to model total body clearance of laropiprant (MK-0524) in humans. Xenobiotica DOI: 10.3109/00498254.2013.791761 [published ahead of print].
-
(2013)
Xenobiotica
-
-
Gibson, C.R.1
Lu, P.2
Maciolek, C.3
Wudarski, C.4
Barter, Z.5
Rowland-Yeo, K.6
Stroh, M.7
Lai, E.8
Nicoll-Griffith, D.A.9
-
68
-
-
0015212973
-
Factors affecting drug metabolism
-
Gillette JR (1971) Factors affecting drug metabolism. Ann N Y Acad Sci 179:43-66.
-
(1971)
Ann N Y Acad Sci
, vol.179
, pp. 43-66
-
-
Gillette, J.R.1
-
69
-
-
33645404135
-
In silico human and rat Vss quantitative structure-activity relationship models
-
Gleeson MP, Waters NJ, Paine SW, and Davis AM (2006) In silico human and rat Vss quantitative structure-activity relationship models. J Med Chem 49:1953-1963.
-
(2006)
J Med Chem
, vol.49
, pp. 1953-1963
-
-
Gleeson, M.P.1
Waters, N.J.2
Paine, S.W.3
Davis, A.M.4
-
70
-
-
84877079740
-
In vivo quantitative prediction of the effect of gene polymorphisms and drug interactions on drug exposure for CYP2C19 substrates
-
Goutelle S, Bourguignon L, Bleyzac N, Berry J, Clavel-Grabit F, and Tod M (2013) In vivo quantitative prediction of the effect of gene polymorphisms and drug interactions on drug exposure for CYP2C19 substrates. AAPS J 15:415-426.
-
(2013)
AAPS J
, vol.15
, pp. 415-426
-
-
Goutelle, S.1
Bourguignon, L.2
Bleyzac, N.3
Berry, J.4
Clavel-Grabit, F.5
Tod, M.6
-
71
-
-
68149151186
-
Effects of drug transporters on volume of distribution
-
Grover A and Benet LZ (2009) Effects of drug transporters on volume of distribution. AAPS J 11:250-261.
-
(2009)
AAPS J
, vol.11
, pp. 250-261
-
-
Grover, A.1
Benet, L.Z.2
-
72
-
-
78650016675
-
Assessment of algorithms for predicting drug-drug interactions via inhibition mechanisms: Comparison of dynamic and static models
-
Guest EJ, Rowland-Yeo K, Rostami-Hodjegan A, Tucker GT, Houston JB, and Galetin A (2011) Assessment of algorithms for predicting drug-drug interactions via inhibition mechanisms: comparison of dynamic and static models. Br J Clin Pharmacol 71:72-87.
-
(2011)
Br J Clin Pharmacol
, vol.71
, pp. 72-87
-
-
Guest, E.J.1
Rowland-Yeo, K.2
Rostami-Hodjegan, A.3
Tucker, G.T.4
Houston, J.B.5
Galetin, A.6
-
73
-
-
78049375674
-
General review on in vitro hepatocyte models and their applications
-
Guguen-Guillouzo C and Guillouzo A (2010) General review on in vitro hepatocyte models and their applications. Methods Mol Biol 640:1-40.
-
(2010)
Methods Mol Biol
, vol.640
, pp. 1-40
-
-
Guguen-Guillouzo, C.1
Guillouzo, A.2
-
74
-
-
78049385182
-
Using open source computational tools for predicting human metabolic stability and additional absorption, distribution, metabolism, excretion, and toxicity properties
-
Gupta RR, Gifford EM, Liston T, Waller CL, Hohman M, Bunin BA, and Ekins S (2010) Using open source computational tools for predicting human metabolic stability and additional absorption, distribution, metabolism, excretion, and toxicity properties. Drug Metab Dispos 38:2083-2090.
-
(2010)
Drug Metab Dispos
, vol.38
, pp. 2083-2090
-
-
Gupta, R.R.1
Gifford, E.M.2
Liston, T.3
Waller, C.L.4
Hohman, M.5
Bunin, B.A.6
Ekins, S.7
-
75
-
-
77957344287
-
Prediction of human metabolic clearance from in vitro systems: Retrospective analysis and prospective view
-
Hallifax D, Foster JA, and Houstion JB (2010) Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view. Pharm Res 27:2150-2161.
-
(2010)
Pharm Res
, vol.27
, pp. 2150-2161
-
-
Hallifax, D.1
Foster, J.A.2
Houstion, J.B.3
-
76
-
-
84855405567
-
Quantification of human uridine-diphosphate glucuronosyl transferase 1A isoforms in liver, intestine, and kidney using nanobore liquid chromatography-tandem mass spectrometry
-
Harbourt DE, Fallon JK, Ito S, Baba T, Ritter JK, Glish GL, and Smith PC (2012) Quantification of human uridine-diphosphate glucuronosyl transferase 1A isoforms in liver, intestine, and kidney using nanobore liquid chromatography-tandem mass spectrometry. Anal Chem 84:98-105.
-
(2012)
Anal Chem
, vol.84
, pp. 98-105
-
-
Harbourt, D.E.1
Fallon, J.K.2
Ito, S.3
Baba, T.4
Ritter, J.K.5
Glish, G.L.6
Smith, P.C.7
-
77
-
-
33845370513
-
Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning
-
Hollósy F, Valkó K, Hersey A, Nunhuck S, Kéri G, and Bevan C (2006) Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning. J Med Chem 49:6958-6971.
-
(2006)
J Med Chem
, vol.49
, pp. 6958-6971
-
-
Hollósy, F.1
Valkó, K.2
Hersey, A.3
Nunhuck, S.4
Kéri, G.5
Bevan, C.6
-
78
-
-
65449166750
-
Prediction of human pharmacokinetics from preclinical information: Comparative accuracy of quantitative prediction approaches
-
Hosea NA, Collard WT, Cole S, Maurer TS, Fang RX, Jones H, Kakar SM, Nakai Y, Smith BJ, and Webster R, et al. (2009) Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches. J Clin Pharmacol 49:513-533.
-
(2009)
J Clin Pharmacol
, vol.49
, pp. 513-533
-
-
Hosea, N.A.1
Collard, W.T.2
Cole, S.3
Maurer, T.S.4
Fang, R.X.5
Jones, H.6
Kakar, S.M.7
Nakai, Y.8
Smith, B.J.9
Webster, R.10
-
79
-
-
0028342648
-
Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance
-
Houston JB (1994) Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol 47:1469-1479.
-
(1994)
Biochem Pharmacol
, vol.47
, pp. 1469-1479
-
-
Houston, J.B.1
-
80
-
-
84862777920
-
The role of physiologically based pharmacokinetic modeling in regulatory review
-
Huang SM and Rowland M (2012) The role of physiologically based pharmacokinetic modeling in regulatory review. Clin Pharmacol Ther 91:542-549.
-
(2012)
Clin Pharmacol Ther
, vol.91
, pp. 542-549
-
-
Huang, S.M.1
Rowland, M.2
-
81
-
-
33745181651
-
Prediction of in vivo drug clearance from in vitro data. II: Potential interethnic differences
-
Inoue S, Howgate EM, Rowland-Yeo K, Shimada T, Yamazaki H, Tucker GT, and Rostami-Hodjegan A (2006) Prediction of in vivo drug clearance from in vitro data. II: potential interethnic differences. Xenobiotica 36:499-513.
-
(2006)
Xenobiotica
, vol.36
, pp. 499-513
-
-
Inoue, S.1
Howgate, E.M.2
Rowland-Yeo, K.3
Shimada, T.4
Yamazaki, H.5
Tucker, G.T.6
Rostami-Hodjegan, A.7
-
82
-
-
0032949615
-
MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening
-
Irvine JD, Takahashi L, Lockhart K, Cheong J, Tolan JW, Selick HE, and Grove JR (1999) MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. J Pharm Sci 88:28-33.
-
(1999)
J Pharm Sci
, vol.88
, pp. 28-33
-
-
Irvine, J.D.1
Takahashi, L.2
Lockhart, K.3
Cheong, J.4
Tolan, J.W.5
Selick, H.E.6
Grove, J.R.7
-
83
-
-
0028845523
-
How does the MRP/GS-X pump export doxorubicin?
-
Ishikawa T, Akimaru K, Kuo MT, Priebe W, and Suzuki M (1995) How does the MRP/GS-X pump export doxorubicin? J Natl Cancer Inst 87:1639-1640.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 1639-1640
-
-
Ishikawa, T.1
Akimaru, K.2
Kuo, M.T.3
Priebe, W.4
Suzuki, M.5
-
84
-
-
18844369894
-
Impact of parallel pathways of drug elimination and multiple cytochrome P450 involvement on drug-drug interactions: CYP2D6 paradigm
-
Ito K, Hallifax D, Obach RS, and Houston JB (2005) Impact of parallel pathways of drug elimination and multiple cytochrome P450 involvement on drug-drug interactions: CYP2D6 paradigm. Drug Metab Dispos 33:837-844.
-
(2005)
Drug Metab Dispos
, vol.33
, pp. 837-844
-
-
Ito, K.1
Hallifax, D.2
Obach, R.S.3
Houston, J.B.4
-
85
-
-
0030937636
-
Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data
-
Iwatsubo T, Hirota N, Ooie T, Suzuki H, Shimada N, Chiba K, Ishizaki T, Green CE, Tyson CA, and Sugiyama Y (1997) Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. Pharmacol Ther 73:147-171.
-
(1997)
Pharmacol Ther
, vol.73
, pp. 147-171
-
-
Iwatsubo, T.1
Hirota, N.2
Ooie, T.3
Suzuki, H.4
Shimada, N.5
Chiba, K.6
Ishizaki, T.7
Green, C.E.8
Tyson, C.A.9
Sugiyama, Y.10
-
86
-
-
67649131017
-
The Simcyp population-based ADME simulator
-
Jamei M, Marciniak S, Feng K, Barnett A, Tucker G, and Rostami-Hodjegan A (2009c) The Simcyp population-based ADME simulator. Expert Opin Drug Metab Toxicol 5:211-223.
-
(2009)
Expert Opin Drug Metab Toxicol
, vol.5
, pp. 211-223
-
-
Jamei, M.1
Marciniak, S.2
Feng, K.3
Barnett, A.4
Tucker, G.5
Rostami-Hodjegan, A.6
-
87
-
-
67649131017
-
The Simcyp population-based ADME simulator
-
Jamei M, Marciniak S, Feng K, Barnett A, Tucker G, and Rostami-Hodjegan A (2009a) The Simcyp population-based ADME simulator. Expert Opin Drug Metab Toxicol 5:211-223.
-
(2009)
Expert Opin Drug Metab Toxicol
, vol.5
, pp. 211-223
-
-
Jamei, M.1
Marciniak, S.2
Feng, K.3
Barnett, A.4
Tucker, G.5
Rostami-Hodjegan, A.6
-
88
-
-
68249155031
-
Population-based mechanistic prediction of oral drug absorption
-
Jamei M, Turner D, Yang J, Neuhoff S, Polak S, Rostami-Hodjegan A, and Tucker G (2009b) Population-based mechanistic prediction of oral drug absorption. AAPS J 11:225-237.
-
(2009)
AAPS J
, vol.11
, pp. 225-237
-
-
Jamei, M.1
Turner, D.2
Yang, J.3
Neuhoff, S.4
Polak, S.5
Rostami-Hodjegan, A.6
Tucker, G.7
-
89
-
-
0028206698
-
Fluconazole: Interspecies scaling and allometric relationships of pharmacokinetic properties
-
Jezequel SG (1994) Fluconazole: interspecies scaling and allometric relationships of pharmacokinetic properties. J Pharm Pharmacol 46:196-199.
-
(1994)
J Pharm Pharmacol
, vol.46
, pp. 196-199
-
-
Jezequel, S.G.1
-
90
-
-
84863968343
-
Utility of drug depletion-time profiles in isolated hepatocytes for accessing hepatic uptake clearance: Identifying rate-limiting steps and role of passive processes
-
Jigorel E and Houston JB (2012) Utility of drug depletion-time profiles in isolated hepatocytes for accessing hepatic uptake clearance: identifying rate-limiting steps and role of passive processes. Drug Metab Dispos 40:1596-1602.
-
(2012)
Drug Metab Dispos
, vol.40
, pp. 1596-1602
-
-
Jigorel, E.1
Houston, J.B.2
-
91
-
-
84859910816
-
Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data
-
Jones HM, Barton HA, Lai Y, Bi YA, Kimoto E, Kempshall S, Tate SC, El-Kattan A, Houston JB, and Galetin A, et al. (2012) Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data. Drug Metab Dispos 40:1007-1017.
-
(2012)
Drug Metab Dispos
, vol.40
, pp. 1007-1017
-
-
Jones, H.M.1
Barton, H.A.2
Lai, Y.3
Bi, Y.A.4
Kimoto, E.5
Kempshall, S.6
Tate, S.C.7
El-Kattan, A.8
Houston, J.B.9
Galetin, A.10
-
92
-
-
79953296456
-
Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modelling
-
Jones HM, Gardner IB, Collard WT, Stanley PJ, Oxley P, Hosea NA, Plowchalk D, Gernhardt S, Lin J, and Dickins M, et al. (2011a) Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modelling. Clin Pharmacokinet 50:331-347.
-
(2011)
Clin Pharmacokinet
, vol.50
, pp. 331-347
-
-
Jones, H.M.1
Gardner, I.B.2
Collard, W.T.3
Stanley, P.J.4
Oxley, P.5
Hosea, N.A.6
Plowchalk, D.7
Gernhardt, S.8
Lin, J.9
Dickins, M.10
-
93
-
-
80052267476
-
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: Comparative assessment of prediction methods of human volume of distribution
-
Jones RD, Jones HM, Rowland M, Gibson CR, Yates JW, Chien JY, Ring BJ, Adkison KK, Ku MS, and He H, et al.. (2011b) PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: Comparative assessment of prediction methods of human volume of distribution. J Pharm Sci 100:4074-4089.
-
(2011)
J Pharm Sci
, vol.100
, pp. 4074-4089
-
-
Jones, R.D.1
Jones, H.M.2
Rowland, M.3
Gibson, C.R.4
Yates, J.W.5
Chien, J.Y.6
Ring, B.J.7
Adkison, K.K.8
Ku, M.S.9
He, H.10
-
94
-
-
56149107690
-
Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphism
-
Kalliokoski A, Backman JT, Kurkinen KJ, Neuvonen PJ, and Niemi M (2008) Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphism. Clin Pharmacol Ther 84:488-496.
-
(2008)
Clin Pharmacol Ther
, vol.84
, pp. 488-496
-
-
Kalliokoski, A.1
Backman, J.T.2
Kurkinen, K.J.3
Neuvonen, P.J.4
Niemi, M.5
-
95
-
-
0030638506
-
Hepatic canalicular membrane. Introduction: Transport across the hepatocyte canalicular membrane
-
Keppler D and Arias IM (1997) Hepatic canalicular membrane. Introduction: transport across the hepatocyte canalicular membrane. FASEB J 11:15-18.
-
(1997)
FASEB J
, vol.11
, pp. 15-18
-
-
Keppler, D.1
Arias, I.M.2
-
96
-
-
0030752006
-
Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2
-
Keppler D, Leier I, and Jedlitschky G (1997) Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 378:787-791.
-
(1997)
Biol Chem
, vol.378
, pp. 787-791
-
-
Keppler, D.1
Leier, I.2
Jedlitschky, G.3
-
97
-
-
15244342411
-
UDP-glucuronosyltransferases and clinical drug-drug interactions
-
Kiang TK, Ensom MH, and Chang TK (2005) UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther 106:97-132.
-
(2005)
Pharmacol Ther
, vol.106
, pp. 97-132
-
-
Kiang, T.K.1
Ensom, M.H.2
Chang, T.K.3
-
98
-
-
58149472377
-
Prediction of drug clearance by glucuronidation from in vitro data: Use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes
-
Kilford PJ, Stringer R, Sohal B, Houston JB, and Galetin A (2009) Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes. Drug Metab Dispos 37:82-89.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 82-89
-
-
Kilford, P.J.1
Stringer, R.2
Sohal, B.3
Houston, J.B.4
Galetin, A.5
-
99
-
-
78650730960
-
Characterization of digoxin uptake in sandwich-cultured human hepatocytes
-
Kimoto E, Chupka J, Xiao Y, Bi YA, and Duignan DB (2011) Characterization of digoxin uptake in sandwich-cultured human hepatocytes. Drug Metab Dispos 39:47-53.
-
(2011)
Drug Metab Dispos
, vol.39
, pp. 47-53
-
-
Kimoto, E.1
Chupka, J.2
Xiao, Y.3
Bi, Y.A.4
Duignan, D.B.5
-
100
-
-
84862934885
-
Differential modulation of cytochrome P450 activity and the effect of 1-aminobenzotriazole on hepatic transport in sandwich-cultured human hepatocytes
-
Kimoto E, Walsky R, Zhang H, Bi YA, Whalen KM, Yang YS, Linder C, Xiao Y, Iseki K, and Fenner KS, et al. (2012a) Differential modulation of cytochrome P450 activity and the effect of 1-aminobenzotriazole on hepatic transport in sandwich-cultured human hepatocytes. Drug Metab Dispos 40:407-411.
-
(2012)
Drug Metab Dispos
, vol.40
, pp. 407-411
-
-
Kimoto, E.1
Walsky, R.2
Zhang, H.3
Bi, Y.A.4
Whalen, K.M.5
Yang, Y.S.6
Linder, C.7
Xiao, Y.8
Iseki, K.9
Fenner, K.S.10
-
101
-
-
84870539183
-
Characterization of Organic Anion Transporting Polypeptide (OATP) Expression and Its Functional Contribution to the Uptake of Substrates in Human Hepatocytes
-
Kimoto E, Yoshida K, Balogh LM, Bi YA, Maeda K, El-Kattan A, Sugiyama Y, and Lai Y (2012b) Characterization of Organic Anion Transporting Polypeptide (OATP) Expression and Its Functional Contribution to the Uptake of Substrates in Human Hepatocytes. Mol Pharm 9:3535-3542.
-
(2012)
Mol Pharm
, vol.9
, pp. 3535-3542
-
-
Kimoto, E.1
Yoshida, K.2
Balogh, L.M.3
Bi, Y.A.4
Maeda, K.5
El-Kattan, A.6
Sugiyama, Y.7
Lai, Y.8
-
102
-
-
4344645978
-
Can the pharmaceutical industry reduce attrition rates?
-
Kola I and Landis J (2004) Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3:711-715.
-
(2004)
Nat Rev Drug Discov
, vol.3
, pp. 711-715
-
-
Kola, I.1
Landis, J.2
-
103
-
-
80051957400
-
Culture period-dependent changes in the uptake of transporter substrates in sandwich-cultured rat and human hepatocytes
-
Kotani N, Maeda K, Watanabe T, Hiramatsu M, Gong LK, Bi YA, Takezawa T, Kusuhara H, and Sugiyama Y (2011) Culture period-dependent changes in the uptake of transporter substrates in sandwich-cultured rat and human hepatocytes. Drug Metab Dispos 39:1503-1510.
-
(2011)
Drug Metab Dispos
, vol.39
, pp. 1503-1510
-
-
Kotani, N.1
Maeda, K.2
Watanabe, T.3
Hiramatsu, M.4
Gong, L.K.5
Bi, Y.A.6
Takezawa, T.7
Kusuhara, H.8
Sugiyama, Y.9
-
104
-
-
59949086334
-
Application of allometry principles for the prediction of human pharmacokinetic parameters for irbesartan, a AT1 receptor antagonist, from animal data
-
Kumar VV and Srinivas NR (2008) Application of allometry principles for the prediction of human pharmacokinetic parameters for irbesartan, a AT1 receptor antagonist, from animal data. Eur J Drug Metab Pharmacokinet 33:247-252.
-
(2008)
Eur J Drug Metab Pharmacokinet
, vol.33
, pp. 247-252
-
-
Kumar, V.V.1
Srinivas, N.R.2
-
105
-
-
66449128354
-
In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney
-
Kusuhara H and Sugiyama Y (2009) In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney. Drug Metab Pharmacokinet 24:37-52.
-
(2009)
Drug Metab Pharmacokinet
, vol.24
, pp. 37-52
-
-
Kusuhara, H.1
Sugiyama, Y.2
-
106
-
-
70349399011
-
Identification of interspecies difference in hepatobiliary transporters to improve extrapolation of human biliary secretion
-
Lai Y (2009) Identification of interspecies difference in hepatobiliary transporters to improve extrapolation of human biliary secretion. Expert Opin Drug Metab Toxicol 5:1175-1187.
-
(2009)
Expert Opin Drug Metab Toxicol
, vol.5
, pp. 1175-1187
-
-
Lai, Y.1
-
107
-
-
84862076531
-
Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - Considerations for drug development
-
Lai Y, Varma M, Feng B, Stephens JC, Kimoto E, El-Kattan A, Ichikawa K, Kikkawa H, Ono C, and Suzuki A, et al. (2012) Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development. Expert Opin Drug Metab Toxicol 8:723-743.
-
(2012)
Expert Opin Drug Metab Toxicol
, vol.8
, pp. 723-743
-
-
Lai, Y.1
Varma, M.2
Feng, B.3
Stephens, J.C.4
Kimoto, E.5
El-Kattan, A.6
Ichikawa, K.7
Kikkawa, H.8
Ono, C.9
Suzuki, A.10
-
108
-
-
6944219986
-
Hepatic microsome studies are insufficient to characterize in vivo hepatic metabolic clearance and metabolic drug-drug interactions: Studies of digoxin metabolism in primary rat hepatocytes versus microsomes
-
Lam JL and Benet LZ (2004) Hepatic microsome studies are insufficient to characterize in vivo hepatic metabolic clearance and metabolic drug-drug interactions: studies of digoxin metabolism in primary rat hepatocytes versus microsomes. Drug Metab Dispos 32:1311-1316.
-
(2004)
Drug Metab Dispos
, vol.32
, pp. 1311-1316
-
-
Lam, J.L.1
Benet, L.Z.2
-
109
-
-
0032921527
-
Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations
-
Lavé T, Coassolo P, and Reigner B (1999) Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations. Clin Pharmacokinet 36:211-231.
-
(1999)
Clin Pharmacokinet
, vol.36
, pp. 211-231
-
-
Lavé, T.1
Coassolo, P.2
Reigner, B.3
-
110
-
-
0030918716
-
Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: Application to 10 extensively metabolized drugs
-
Lave T, Dupin S, Schmitt C, Chou RC, Jaeck D, and Coassolo P (1997) Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. J Pharm Sci 86:584-590.
-
(1997)
J Pharm Sci
, vol.86
, pp. 584-590
-
-
Lave, T.1
Dupin, S.2
Schmitt, C.3
Chou, R.C.4
Jaeck, D.5
Coassolo, P.6
-
111
-
-
48849087036
-
Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human
-
Li M, Yuan H, Li N, Song G, Zheng Y, Baratta M, Hua F, Thurston A, Wang J, and Lai Y (2008) Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human. Eur J Pharm Sci 35:114-126.
-
(2008)
Eur J Pharm Sci
, vol.35
, pp. 114-126
-
-
Li, M.1
Yuan, H.2
Li, N.3
Song, G.4
Zheng, Y.5
Baratta, M.6
Hua, F.7
Thurston, A.8
Wang, J.9
Lai, Y.10
-
112
-
-
77953284053
-
Improved extrapolation of hepatobiliary clearance from in vitro sandwich cultured rat hepatocytes through absolute quantification of hepatobiliary transporters
-
Li N, Singh P, Mandrell KM, and Lai Y (2010) Improved extrapolation of hepatobiliary clearance from in vitro sandwich cultured rat hepatocytes through absolute quantification of hepatobiliary transporters. Mol Pharm 7:630-641.
-
(2010)
Mol Pharm
, vol.7
, pp. 630-641
-
-
Li, N.1
Singh, P.2
Mandrell, K.M.3
Lai, Y.4
-
113
-
-
0028818229
-
Species similarities and differences in pharmacokinetics
-
Lin JH (1995) Species similarities and differences in pharmacokinetics. Drug Metab Dispos 23:1008-1021.
-
(1995)
Drug Metab Dispos
, vol.23
, pp. 1008-1021
-
-
Lin, J.H.1
-
114
-
-
11144276585
-
The roles of transporters and enzymes in hepatic drug processing
-
Liu L and Pang KS (2005) The roles of transporters and enzymes in hepatic drug processing. Drug Metab Dispos 33:1-9.
-
(2005)
Drug Metab Dispos
, vol.33
, pp. 1-9
-
-
Liu, L.1
Pang, K.S.2
-
115
-
-
0033017134
-
Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats
-
Liu X, Chism JP, LeCluyse EL, Brouwer KR, and Brouwer KL (1999) Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats. Drug Metab Dispos 27:637-644.
-
(1999)
Drug Metab Dispos
, vol.27
, pp. 637-644
-
-
Liu, X.1
Chism, J.P.2
LeCluyse, E.L.3
Brouwer, K.R.4
Brouwer, K.L.5
-
116
-
-
33645675081
-
A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in human
-
Lombardo F, Obach RS, Dicapua FM, Bakken GA, Lu J, Potter DM, Gao F, Miller MD, and Zhang Y (2006) A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in human. J Med Chem 49:2262-2267.
-
(2006)
J Med Chem
, vol.49
, pp. 2262-2267
-
-
Lombardo, F.1
Obach, R.S.2
Dicapua, F.M.3
Bakken, G.A.4
Lu, J.5
Potter, D.M.6
Gao, F.7
Miller, M.D.8
Zhang, Y.9
-
117
-
-
84865484675
-
Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 2: Clearance
-
Lombardo F, Waters NJ, Argikar UA, Dennehy MK, Zhan J, Gunduz M, Harriman SP, Berellini G, Liric Rajlic I, and Obach RS (2013a) Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 2: clearance. J Clin Pharmacol 53:178-191.
-
(2013)
J Clin Pharmacol
, vol.53
, pp. 178-191
-
-
Lombardo, F.1
Waters, N.J.2
Argikar, U.A.3
Dennehy, M.K.4
Zhan, J.5
Gunduz, M.6
Harriman, S.P.7
Berellini, G.8
Liric Rajlic, I.9
Obach, R.S.10
-
118
-
-
84875783673
-
Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 1: Volume of distribution at steady state
-
Lombardo F, Waters NJ, Argikar UA, Dennehy MK, Zhan J, Gunduz M, Harriman SP, Berellini G, Rajlic IL, and Obach RS (2013b) Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 1: volume of distribution at steady state. J Clin Pharmacol 53:167-177.
-
(2013)
J Clin Pharmacol
, vol.53
, pp. 167-177
-
-
Lombardo, F.1
Waters, N.J.2
Argikar, U.A.3
Dennehy, M.K.4
Zhan, J.5
Gunduz, M.6
Harriman, S.P.7
Berellini, G.8
Rajlic, I.L.9
Obach, R.S.10
-
119
-
-
80052968100
-
Identification of the rate-determining process in the hepatic clearance of atorvastatin in a clinical cassette microdosing study
-
Maeda K, Ikeda Y, Fujita T, Yoshida K, Azuma Y, Haruyama Y, Yamane N, Kumagai Y, and Sugiyama Y (2011) Identification of the rate-determining process in the hepatic clearance of atorvastatin in a clinical cassette microdosing study. Clin Pharmacol Ther 90:575-581.
-
(2011)
Clin Pharmacol Ther
, vol.90
, pp. 575-581
-
-
Maeda, K.1
Ikeda, Y.2
Fujita, T.3
Yoshida, K.4
Azuma, Y.5
Haruyama, Y.6
Yamane, N.7
Kumagai, Y.8
Sugiyama, Y.9
-
120
-
-
0032553486
-
Interspecies scaling of renally secreted drugs
-
Mahmood I (1998) Interspecies scaling of renally secreted drugs. Life Sci 63:2365-2371.
-
(1998)
Life Sci
, vol.63
, pp. 2365-2371
-
-
Mahmood, I.1
-
121
-
-
0032822442
-
Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: A comparative study
-
Mahmood I (1999) Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: a comparative study. J Pharm Pharmacol 51:905-910.
-
(1999)
J Pharm Pharmacol
, vol.51
, pp. 905-910
-
-
Mahmood, I.1
-
122
-
-
0035209269
-
Mechanisms and clinical implications of renal drug excretion
-
Masereeuw R and Russel FG (2001) Mechanisms and clinical implications of renal drug excretion. Drug Metab Rev 33:299-351.
-
(2001)
Drug Metab Rev
, vol.33
, pp. 299-351
-
-
Masereeuw, R.1
Russel, F.G.2
-
123
-
-
84865191410
-
Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes
-
Ménochet K, Kenworthy KE, Houston JB, and Galetin A (2012) Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes. Drug Metab Dispos 40:1744-1756.
-
(2012)
Drug Metab Dispos
, vol.40
, pp. 1744-1756
-
-
Ménochet, K.1
Kenworthy, K.E.2
Houston, J.B.3
Galetin, A.4
-
124
-
-
0023033053
-
Man versus beast: Pharmacokinetic scaling in mammals
-
Mordenti J (1986) Man versus beast: pharmacokinetic scaling in mammals. J Pharm Sci 75:1028-1040.
-
(1986)
J Pharm Sci
, vol.75
, pp. 1028-1040
-
-
Mordenti, J.1
-
125
-
-
0030753125
-
Molecular aspects of hepatobiliary transport
-
Müller M and Jansen PL (1997) Molecular aspects of hepatobiliary transport. Am J Physiol 272:G1285-G1303.
-
(1997)
Am J Physiol
, vol.272
-
-
Müller, M.1
Jansen, P.L.2
-
126
-
-
20444466590
-
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
-
Niemi M, Backman JT, Kajosaari LI, Leathart JB, Neuvonen M, Daly AK, Eichelbaum M, Kivistö KT, and Neuvonen PJ (2005) Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics. Clin Pharmacol Ther 77:468-478.
-
(2005)
Clin Pharmacol Ther
, vol.77
, pp. 468-478
-
-
Niemi, M.1
Backman, J.T.2
Kajosaari, L.I.3
Leathart, J.B.4
Neuvonen, M.5
Daly, A.K.6
Eichelbaum, M.7
Kivistö, K.T.8
Neuvonen, P.J.9
-
127
-
-
79953901458
-
Organic anion transporting polypeptide 1B1: A genetically polymorphic transporter of major importance for hepatic drug uptake
-
Niemi M, Pasanen MK, and Neuvonen PJ (2011) Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev 63:157-181.
-
(2011)
Pharmacol Rev
, vol.63
, pp. 157-181
-
-
Niemi, M.1
Pasanen, M.K.2
Neuvonen, P.J.3
-
128
-
-
78049367110
-
Prediction of the intestinal first-pass metabolism of CYP3A substrates in humans using cynomolgus monkeys
-
Nishimuta H, Sato K, Mizuki Y, Yabuki M, and Komuro S (2010) Prediction of the intestinal first-pass metabolism of CYP3A substrates in humans using cynomolgus monkeys. Drug Metab Dispos 38:1967-1975.
-
(2010)
Drug Metab Dispos
, vol.38
, pp. 1967-1975
-
-
Nishimuta, H.1
Sato, K.2
Mizuki, Y.3
Yabuki, M.4
Komuro, S.5
-
129
-
-
0031466149
-
Nonspecific binding to microsomes: Impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol
-
Obach RS (1997) Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. Drug Metab Dispos 25:1359-1369.
-
(1997)
Drug Metab Dispos
, vol.25
, pp. 1359-1369
-
-
Obach, R.S.1
-
130
-
-
0032733974
-
Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes
-
Obach RS (1999) Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos 27:1350-1359.
-
(1999)
Drug Metab Dispos
, vol.27
, pp. 1350-1359
-
-
Obach, R.S.1
-
131
-
-
0033840074
-
Metabolism of ezlopitant, a nonpeptidic substance P receptor antagonist, in liver microsomes: Enzyme kinetics, cytochrome P450 isoform identity, and in vitro-in vivo correlation
-
Obach RS (2000) Metabolism of ezlopitant, a nonpeptidic substance P receptor antagonist, in liver microsomes: enzyme kinetics, cytochrome P450 isoform identity, and in vitro-in vivo correlation. Drug Metab Dispos 28:1069-1076.
-
(2000)
Drug Metab Dispos
, vol.28
, pp. 1069-1076
-
-
Obach, R.S.1
-
132
-
-
35748934513
-
Prediction of human volume of distribution using in vivo, in vitro, and in silico approaches
-
Obach RS (2007) Prediction of human volume of distribution using in vivo, in vitro, and in silico approaches. Annu Rep Med Chem 42:469-488.
-
(2007)
Annu Rep Med Chem
, vol.42
, pp. 469-488
-
-
Obach, R.S.1
-
133
-
-
58449091215
-
Predicting drug-drug interactions from in vitro drug metabolism data: Challenges and recent advances
-
Obach RS (2009) Predicting drug-drug interactions from in vitro drug metabolism data: challenges and recent advances. Curr Opin Drug Discov Devel 12:81-89.
-
(2009)
Curr Opin Drug Discov Devel
, vol.12
, pp. 81-89
-
-
Obach, R.S.1
-
134
-
-
0030799001
-
The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data
-
Obach RS, Baxter JG, Liston TE, Silber BM, Jones BC, MacIntyre F, Rance DJ, and Wastall P (1997) The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. J Pharmacol Exp Ther 283:46-58.
-
(1997)
J Pharmacol Exp Ther
, vol.283
, pp. 46-58
-
-
Obach, R.S.1
Baxter, J.G.2
Liston, T.E.3
Silber, B.M.4
Jones, B.C.5
MacIntyre, F.6
Rance, D.J.7
Wastall, P.8
-
135
-
-
29244447987
-
The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions
-
Obach RS, Walsky RL, Venkatakrishnan K, Gaman EA, Houston JB, and Tremaine LM (2006) The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions. J Pharmacol Exp Ther 316:336-348.
-
(2006)
J Pharmacol Exp Ther
, vol.316
, pp. 336-348
-
-
Obach, R.S.1
Walsky, R.L.2
Venkatakrishnan, K.3
Gaman, E.A.4
Houston, J.B.5
Tremaine, L.M.6
-
136
-
-
1842432543
-
Biopharmaceutics classification by high throughput solubility assay and PAMPA
-
Obata K, Sugano K, Machida M, and Aso Y (2004) Biopharmaceutics classification by high throughput solubility assay and PAMPA. Drug Dev Ind Pharm 30:181-185.
-
(2004)
Drug Dev Ind Pharm
, vol.30
, pp. 181-185
-
-
Obata, K.1
Sugano, K.2
Machida, M.3
Aso, Y.4
-
137
-
-
84455194082
-
Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: Comparison with mRNA levels and activities
-
Ohtsuki S, Schaefer O, Kawakami H, Inoue T, Liehner S, Saito A, Ishiguro N, Kishimoto W, Ludwig-Schwellinger E, and Ebner T, et al. (2012) Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities. Drug Metab Dispos 40:83-92.
-
(2012)
Drug Metab Dispos
, vol.40
, pp. 83-92
-
-
Ohtsuki, S.1
Schaefer, O.2
Kawakami, H.3
Inoue, T.4
Liehner, S.5
Saito, A.6
Ishiguro, N.7
Kishimoto, W.8
Ludwig-Schwellinger, E.9
Ebner, T.10
-
138
-
-
0018668570
-
Effect of altered plasma protein binding on apparent volume of distribution
-
Oie S and Tozer TN (1979) Effect of altered plasma protein binding on apparent volume of distribution. J Pharm Sci 68:1203-1205.
-
(1979)
J Pharm Sci
, vol.68
, pp. 1203-1205
-
-
Oie, S.1
Tozer, T.N.2
-
139
-
-
33645809139
-
The human intestinal cytochrome P450 "pie"
-
Paine MF, Hart HL, Ludington SS, Haining RL, Rettie AE, and Zeldin DC (2006) The human intestinal cytochrome P450 "pie". Drug Metab Dispos 34:880-886.
-
(2006)
Drug Metab Dispos
, vol.34
, pp. 880-886
-
-
Paine, M.F.1
Hart, H.L.2
Ludington, S.S.3
Haining, R.L.4
Rettie, A.E.5
Zeldin, D.C.6
-
140
-
-
0029738490
-
First-pass metabolism of midazolam by the human intestine
-
Paine MF, Shen DD, Kunze KL, Perkins JD, Marsh CL, McVicar JP, Barr DM, Gillies BS, and Thummel KE (1996) First-pass metabolism of midazolam by the human intestine. Clin Pharmacol Ther 60:14-24.
-
(1996)
Clin Pharmacol Ther
, vol.60
, pp. 14-24
-
-
Paine, M.F.1
Shen, D.D.2
Kunze, K.L.3
Perkins, J.D.4
Marsh, C.L.5
McVicar, J.P.6
Barr, D.M.7
Gillies, B.S.8
Thummel, K.E.9
-
141
-
-
79956123094
-
Prediction of human renal clearance from preclinical species for a diverse set of drugs that exhibit both active secretion and net reabsorption
-
Paine SW, Ménochet K, Denton R, McGinnity DF, and Riley RJ (2011) Prediction of human renal clearance from preclinical species for a diverse set of drugs that exhibit both active secretion and net reabsorption. Drug Metab Dispos 39:1008-1013.
-
(2011)
Drug Metab Dispos
, vol.39
, pp. 1008-1013
-
-
Paine, S.W.1
Ménochet, K.2
Denton, R.3
McGinnity, D.F.4
Riley, R.J.5
-
142
-
-
0017603437
-
Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance
-
Pang KS and Rowland M (1977) Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J Pharmacokinet Biopharm 5:625-653.
-
(1977)
J Pharmacokinet Biopharm
, vol.5
, pp. 625-653
-
-
Pang, K.S.1
Rowland, M.2
-
143
-
-
46449096570
-
Rate-limiting steps in hepatic drug clearance: Comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir
-
Parker AJ and Houston JB (2008) Rate-limiting steps in hepatic drug clearance: comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir. Drug Metab Dispos 36:1375-1384.
-
(2008)
Drug Metab Dispos
, vol.36
, pp. 1375-1384
-
-
Parker, A.J.1
Houston, J.B.2
-
144
-
-
84881609631
-
Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data
-
Poulin P and Haddad S (2013) Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data. J Pharm Sci 102:3239-3251.
-
(2013)
J Pharm Sci
, vol.102
, pp. 3239-3251
-
-
Poulin, P.1
Haddad, S.2
-
145
-
-
0036144815
-
Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution
-
Poulin P and Theil F-P (2002) Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. J Pharm Sci 91:129-156.
-
(2002)
J Pharm Sci
, vol.91
, pp. 129-156
-
-
Poulin, P.1
Theil, F.-P.2
-
146
-
-
1542344547
-
Predicting drug clearance from recombinantly expressed CYPs: Intersystem extrapolation factors
-
Proctor NJ, Tucker GT, and Rostami-Hodjegan A (2004) Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors. Xenobiotica 34:151-178.
-
(2004)
Xenobiotica
, vol.34
, pp. 151-178
-
-
Proctor, N.J.1
Tucker, G.T.2
Rostami-Hodjegan, A.3
-
147
-
-
0017335453
-
Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance
-
Rane A, Wilkinson GR, and Shand DG (1977) Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance. J Pharmacol Exp Ther 200:420-424.
-
(1977)
J Pharmacol Exp Ther
, vol.200
, pp. 420-424
-
-
Rane, A.1
Wilkinson, G.R.2
Shand, D.G.3
-
148
-
-
84868204415
-
Tissue lipids and drug distribution: Dog versus rat
-
Rodgers T, Jones HM, and Rowland M (2012) Tissue lipids and drug distribution: dog versus rat. J Pharm Sci 101:4615-4626.
-
(2012)
J Pharm Sci
, vol.101
, pp. 4615-4626
-
-
Rodgers, T.1
Jones, H.M.2
Rowland, M.3
-
149
-
-
21344469211
-
Physiologically based pharmacokinetic modeling 1: Predicting the tissue distribution of moderate-to-strong bases
-
Rodgers T, Leahy D, and Rowland M (2005) Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. J Pharm Sci 94:1259-1276.
-
(2005)
J Pharm Sci
, vol.94
, pp. 1259-1276
-
-
Rodgers, T.1
Leahy, D.2
Rowland, M.3
-
150
-
-
33745055239
-
Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions
-
Rodgers T and Rowland M (2006) Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. J Pharm Sci 95:1238-1257.
-
(2006)
J Pharm Sci
, vol.95
, pp. 1238-1257
-
-
Rodgers, T.1
Rowland, M.2
-
151
-
-
34247556082
-
Mechanistic approaches to volume of distribution predictions: Understanding the processes
-
Rodgers T and Rowland M (2007) Mechanistic approaches to volume of distribution predictions: understanding the processes. Pharm Res 24:918-933.
-
(2007)
Pharm Res
, vol.24
, pp. 918-933
-
-
Rodgers, T.1
Rowland, M.2
-
152
-
-
84862619047
-
Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: A marriage under the arch of systems pharmacology
-
Rostami-Hodjegan A (2012) Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology. Clin Pharmacol Ther 92:50-61.
-
(2012)
Clin Pharmacol Ther
, vol.92
, pp. 50-61
-
-
Rostami-Hodjegan, A.1
-
153
-
-
0036614033
-
The effects of portal shunts on intestinal cytochrome P450 3A activity
-
Rostami-Hodjegan A and Tucker GT (2002) The effects of portal shunts on intestinal cytochrome P450 3A activity. Hepatology 35:1549-1550.
-
(2002)
Hepatology
, vol.35
, pp. 1549-1550
-
-
Rostami-Hodjegan, A.1
Tucker, G.T.2
-
157
-
-
77549084821
-
Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut - The effect of diltiazem on the time-course of exposure to triazolam
-
Rowland Yeo K, Jamei M, Yang J, Tucker GT, and Rostami-Hodjegan A (2010) Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut - the effect of diltiazem on the time-course of exposure to triazolam. Eur J Pharm Sci 39:298-309.
-
(2010)
Eur J Pharm Sci
, vol.39
, pp. 298-309
-
-
Rowland Yeo, K.1
Jamei, M.2
Yang, J.3
Tucker, G.T.4
Rostami-Hodjegan, A.5
-
158
-
-
79957493995
-
Prediction of time-dependent CYP3A4 drug-drug interactions by physiologically based pharmacokinetic modelling: Impact of inactivation parameters and enzyme turnover
-
Rowland Yeo K, Walsky RL, Jamei M, Rostami-Hodjegan A, and Tucker GT (2011) Prediction of time-dependent CYP3A4 drug-drug interactions by physiologically based pharmacokinetic modelling: impact of inactivation parameters and enzyme turnover. Eur J Pharm Sci 43:160-173.
-
(2011)
Eur J Pharm Sci
, vol.43
, pp. 160-173
-
-
Rowland Yeo, K.1
Walsky, R.L.2
Jamei, M.3
Rostami-Hodjegan, A.4
Tucker, G.T.5
-
159
-
-
0035120237
-
Determination of the aqueous solubility of drugs using a convenient 96-well plate-based assay
-
Roy D, Ducher F, Laumain A, and Legendre JY (2001) Determination of the aqueous solubility of drugs using a convenient 96-well plate-based assay. Drug Dev Ind Pharm 27:107-109.
-
(2001)
Drug Dev Ind Pharm
, vol.27
, pp. 107-109
-
-
Roy, D.1
Ducher, F.2
Laumain, A.3
Legendre, J.Y.4
-
160
-
-
77953571883
-
Understanding the clinical pharmacokinetics of a GABAA partial agonist by application of in vitro tools
-
Sawant AD, Miller EL, Duignan DB, Brodfuehrer J, Winter SM, Nelson FR, Kamel A, Obach RS, and Vaz AD (2010) Understanding the clinical pharmacokinetics of a GABAA partial agonist by application of in vitro tools. Xenobiotica 40:476-484.
-
(2010)
Xenobiotica
, vol.40
, pp. 476-484
-
-
Sawant, A.D.1
Miller, E.L.2
Duignan, D.B.3
Brodfuehrer, J.4
Winter, S.M.5
Nelson, F.R.6
Kamel, A.7
Obach, R.S.8
Vaz, A.D.9
-
161
-
-
84864287453
-
Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins
-
Sharma P, Butters CJ, Smith V, Elsby R, and Surry D (2012) Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins. Eur J Pharm Sci 47:244-255.
-
(2012)
Eur J Pharm Sci
, vol.47
, pp. 244-255
-
-
Sharma, P.1
Butters, C.J.2
Smith, V.3
Elsby, R.4
Surry, D.5
-
162
-
-
84874437997
-
Cynomolgus monkey as a potential model to assess drug interactions involving hepatic organic anion transporting polypeptides (OATPs), in vitro, in vivo and in vitro-to-in vivo extrapolation
-
Shen H, Yang Z, Mintier G, Han Y-H, Chen C, Balimane P, Jemal M, Zhao W, Zhang R, and Kallipatti S, et al. (2013) Cynomolgus monkey as a potential model to assess drug interactions involving hepatic organic anion transporting polypeptides (OATPs), in vitro, in vivo and in vitro-to-in vivo extrapolation. J Pharmacol Exp Ther 344:673-685.
-
(2013)
J Pharmacol Exp Ther
, vol.344
, pp. 673-685
-
-
Shen, H.1
Yang, Z.2
Mintier, G.3
Han, Y.-H.4
Chen, C.5
Balimane, P.6
Jemal, M.7
Zhao, W.8
Zhang, R.9
Kallipatti, S.10
-
163
-
-
33644847684
-
Transporters as a determinant of drug clearance and tissue distribution
-
Shitara Y, Horie T, and Sugiyama Y (2006) Transporters as a determinant of drug clearance and tissue distribution. Eur J Pharm Sci 27:425-446.
-
(2006)
Eur J Pharm Sci
, vol.27
, pp. 425-446
-
-
Shitara, Y.1
Horie, T.2
Sugiyama, Y.3
-
164
-
-
33748042671
-
Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3- methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions
-
Shitara Y and Sugiyama Y (2006) Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacol Ther 112:71-105.
-
(2006)
Pharmacol Ther
, vol.112
, pp. 71-105
-
-
Shitara, Y.1
Sugiyama, Y.2
-
165
-
-
68149170038
-
The role of transporters in the pharmacokinetics of orally administered drugs
-
Shugarts S and Benet LZ (2009) The role of transporters in the pharmacokinetics of orally administered drugs. Pharm Res 26:2039-2054.
-
(2009)
Pharm Res
, vol.26
, pp. 2039-2054
-
-
Shugarts, S.1
Benet, L.Z.2
-
166
-
-
78650748330
-
Identification of clinically used drugs that activate pregnane X receptors
-
Shukla SJ, Sakamuru S, Huang R, Moeller TA, Shinn P, Vanleer D, Auld DS, Austin CP, and Xia M (2011) Identification of clinically used drugs that activate pregnane X receptors. Drug Metab Dispos 39:151-159.
-
(2011)
Drug Metab Dispos
, vol.39
, pp. 151-159
-
-
Shukla, S.J.1
Sakamuru, S.2
Huang, R.3
Moeller, T.A.4
Shinn, P.5
Vanleer, D.6
Auld, D.S.7
Austin, C.P.8
Xia, M.9
-
167
-
-
84858660647
-
From preclinical to human - Prediction of oral absorption and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: A workflow by using case example
-
Sinha VK, Snoeys J, Osselaer NV, Peer AV, Mackie C, and Heald D (2012) From preclinical to human - prediction of oral absorption and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: a workflow by using case example. Biopharm Drug Dispos 33:111-121.
-
(2012)
Biopharm Drug Dispos
, vol.33
, pp. 111-121
-
-
Sinha, V.K.1
Snoeys, J.2
Osselaer, N.V.3
Peer, A.V.4
Mackie, C.5
Heald, D.6
-
168
-
-
53849093733
-
Current industrial practices in assessing CYP450 enzyme induction: Preclinical and clinical
-
Sinz M, Wallace G, and Sahi J (2008) Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical. AAPS J 10:391-400.
-
(2008)
AAPS J
, vol.10
, pp. 391-400
-
-
Sinz, M.1
Wallace, G.2
Sahi, J.3
-
169
-
-
82955239907
-
Pfizer Sandwich Laboratories: Where drug metabolism first met drug discovery
-
Smith D (2012) Pfizer Sandwich Laboratories: where drug metabolism first met drug discovery. Xenobiotica 42:2-3.
-
(2012)
Xenobiotica
, vol.42
, pp. 2-3
-
-
Smith, D.1
-
170
-
-
84863893492
-
The development, characterization, and application of an OATP1B1 inhibition assay in drug discovery
-
Soars MG, Barton P, Ismair M, Jupp R, and Riley RJ (2012) The development, characterization, and application of an OATP1B1 inhibition assay in drug discovery. Drug Metab Dispos 40: 1641-1648.
-
(2012)
Drug Metab Dispos
, vol.40
, pp. 1641-1648
-
-
Soars, M.G.1
Barton, P.2
Ismair, M.3
Jupp, R.4
Riley, R.J.5
-
171
-
-
34249006024
-
Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo
-
Soars MG, Grime K, Sproston JL, Webborn PJ, and Riley RJ (2007) Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo. Drug Metab Dispos 35:859-865.
-
(2007)
Drug Metab Dispos
, vol.35
, pp. 859-865
-
-
Soars, M.G.1
Grime, K.2
Sproston, J.L.3
Webborn, P.J.4
Riley, R.J.5
-
172
-
-
71949098636
-
Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: Use of assays and models for decision making in the pharmaceutical industry
-
Soars MG, Webborn PJ, and Riley RJ (2009) Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry. Mol Pharm 6:1662-1677.
-
(2009)
Mol Pharm
, vol.6
, pp. 1662-1677
-
-
Soars, M.G.1
Webborn, P.J.2
Riley, R.J.3
-
173
-
-
66449122160
-
Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions
-
Stringer RA, Strain-Damerell C, Nicklin P, and Houston JB (2009) Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions. Drug Metab Dispos 37:1025-1034.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 1025-1034
-
-
Stringer, R.A.1
Strain-Damerell, C.2
Nicklin, P.3
Houston, J.B.4
-
174
-
-
78649637016
-
Contribution of molecular properties to extrapolation of the volume of distribution in human from preclinical animal species data
-
Sui X, Sun J, Li H, Pan Y, Wang Y, and He Z (2010) Contribution of molecular properties to extrapolation of the volume of distribution in human from preclinical animal species data. Biopharm Drug Dispos 31:464-475.
-
(2010)
Biopharm Drug Dispos
, vol.31
, pp. 464-475
-
-
Sui, X.1
Sun, J.2
Li, H.3
Pan, Y.4
Wang, Y.5
He, Z.6
-
175
-
-
0033256510
-
Transporters for bile acids and organic anions
-
Suzuki H and Sugiyama Y (1999) Transporters for bile acids and organic anions. Pharm Biotechnol 12:387-439.
-
(1999)
Pharm Biotechnol
, vol.12
, pp. 387-439
-
-
Suzuki, H.1
Sugiyama, Y.2
-
176
-
-
61449118888
-
Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport
-
Syvänen S, Lindhe O, Palner M, Kornum BR, Rahman O, Långström B, Knudsen GM, and Hammarlund-Udenaes M (2009) Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport. Drug Metab Dispos 37:635-643.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 635-643
-
-
Syvänen, S.1
Lindhe, O.2
Palner, M.3
Kornum, B.R.4
Rahman, O.5
Långström, B.6
Knudsen, G.M.7
Hammarlund-Udenaes, M.8
-
177
-
-
79851478871
-
Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein
-
Tachibana T, Kato M, Takano J, and Sugiyama Y (2010) Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein. Curr Drug Metab 11:762-777.
-
(2010)
Curr Drug Metab
, vol.11
, pp. 762-777
-
-
Tachibana, T.1
Kato, M.2
Takano, J.3
Sugiyama, Y.4
-
178
-
-
33644749355
-
Is the monkey an appropriate animal model to examine drug-drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists
-
Tahara H, Kusuhara H, Chida M, Fuse E, and Sugiyama Y (2006) Is the monkey an appropriate animal model to examine drug-drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists. J Pharmacol Exp Ther 316:1187-1194.
-
(2006)
J Pharmacol Exp Ther
, vol.316
, pp. 1187-1194
-
-
Tahara, H.1
Kusuhara, H.2
Chida, M.3
Fuse, E.4
Sugiyama, Y.5
-
179
-
-
18044374088
-
Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney
-
Tahara H, Shono M, Kusuhara H, Kinoshita H, Fuse E, Takadate A, Otagiri M, and Sugiyama Y (2005) Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney. Pharm Res 22:647-660.
-
(2005)
Pharm Res
, vol.22
, pp. 647-660
-
-
Tahara, H.1
Shono, M.2
Kusuhara, H.3
Kinoshita, H.4
Fuse, E.5
Takadate, A.6
Otagiri, M.7
Sugiyama, Y.8
-
180
-
-
70349645316
-
The species differences of intestinal drug absorption and first-pass metabolism between cynomolgus monkeys and humans
-
Takahashi M, Washio T, Suzuki N, Igeta K, and Yamashita S (2009) The species differences of intestinal drug absorption and first-pass metabolism between cynomolgus monkeys and humans. J Pharm Sci 98:4343-4353.
-
(2009)
J Pharm Sci
, vol.98
, pp. 4343-4353
-
-
Takahashi, M.1
Washio, T.2
Suzuki, N.3
Igeta, K.4
Yamashita, S.5
-
181
-
-
0037378726
-
Segmental intestinal transporters and metabolic enzymes on intestinal drug absorption
-
Tam D, Tirona RG, and Pang KS (2003) Segmental intestinal transporters and metabolic enzymes on intestinal drug absorption. Drug Metab Dispos 31:373-383.
-
(2003)
Drug Metab Dispos
, vol.31
, pp. 373-383
-
-
Tam, D.1
Tirona, R.G.2
Pang, K.S.3
-
182
-
-
84859712703
-
Oral drug delivery utilizing intestinal OATP transporters
-
Tamai I (2012) Oral drug delivery utilizing intestinal OATP transporters. Adv Drug Deliv Rev 64:508-514.
-
(2012)
Adv Drug Deliv Rev
, vol.64
, pp. 508-514
-
-
Tamai, I.1
-
183
-
-
33344457255
-
A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry
-
Tang H and Mayersohn M (2006) A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry. J Pharm Sci 95:1783-1799.
-
(2006)
J Pharm Sci
, vol.95
, pp. 1783-1799
-
-
Tang, H.1
Mayersohn, M.2
-
184
-
-
36048955673
-
Gut instincts: CYP3A4 and intestinal drug metabolism
-
Thummel KE (2007) Gut instincts: CYP3A4 and intestinal drug metabolism. J Clin Invest 117:3173-3176.
-
(2007)
J Clin Invest
, vol.117
, pp. 3173-3176
-
-
Thummel, K.E.1
-
185
-
-
84860858293
-
Novel in vitro-in vivo extrapolation (IVIVE) method to predict hepatic organ clearance in rat
-
Umehara K and Camenisch G (2012) Novel in vitro-in vivo extrapolation (IVIVE) method to predict hepatic organ clearance in rat. Pharm Res 29:603-617.
-
(2012)
Pharm Res
, vol.29
, pp. 603-617
-
-
Umehara, K.1
Camenisch, G.2
-
186
-
-
79251578340
-
Estimating unbound volume of distribution and tissue binding by in vitro HPLC-based human serum albumin and immobilised artificial membrane-binding measurements
-
Valkó KL, Nunhuck SB, and Hill AP (2011) Estimating unbound volume of distribution and tissue binding by in vitro HPLC-based human serum albumin and immobilised artificial membrane-binding measurements. J Pharm Sci 100:849-862.
-
(2011)
J Pharm Sci
, vol.100
, pp. 849-862
-
-
Valkó, K.L.1
Nunhuck, S.B.2
Hill, A.P.3
-
187
-
-
71049142699
-
Inhibition and stimulation of intestinal and hepatic CYP3A activity: Studies in humanized CYP3A4 transgenic mice using triazolam
-
van Waterschoot RA, Rooswinkel RW, Sparidans RW, van Herwaarden AE, Beijnen JH, and Schinkel AH (2009) Inhibition and stimulation of intestinal and hepatic CYP3A activity: studies in humanized CYP3A4 transgenic mice using triazolam. Drug Metab Dispos 37:2305-2313.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 2305-2313
-
-
Van Waterschoot, R.A.1
Rooswinkel, R.W.2
Sparidans, R.W.3
Van Herwaarden, A.E.4
Beijnen, J.H.5
Schinkel, A.H.6
-
188
-
-
84863894140
-
Physicochemical property space of hepatobiliary transport and computational models for predicting rat biliary excretion
-
Varma MV, Chang G, Lai Y, Feng B, El-Kattan AF, Litchfield J, and Goosen TC (2012a) Physicochemical property space of hepatobiliary transport and computational models for predicting rat biliary excretion. Drug Metab Dispos 40:1527-1537.
-
(2012)
Drug Metab Dispos
, vol.40
, pp. 1527-1537
-
-
Varma, M.V.1
Chang, G.2
Lai, Y.3
Feng, B.4
El-Kattan, A.F.5
Litchfield, J.6
Goosen, T.C.7
-
189
-
-
84860755198
-
pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery
-
Varma MV, Gardner I, Steyn SJ, Nkansah P, Rotter CJ, Whitney-Pickett C, Zhang H, Di L, Cram M, and Fenner KS, et al. (2012b) pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery. Mol Pharm 9:1199-1212.
-
(2012)
Mol Pharm
, vol.9
, pp. 1199-1212
-
-
Varma, M.V.1
Gardner, I.2
Steyn, S.J.3
Nkansah, P.4
Rotter, C.J.5
Whitney-Pickett, C.6
Zhang, H.7
Cram M, D.L.8
Fenner, K.S.9
-
190
-
-
4644231090
-
Biopharmaceutic classification system: A scientific framework for pharmacokinetic optimization in drug research
-
Varma MV, Khandavilli S, Ashokraj Y, Jain A, Dhanikula A, Sood A, Thomas NS, Pillai O, Sharma P, and Gandhi R, et al. (2004) Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research. Curr Drug Metab 5:375-388.
-
(2004)
Curr Drug Metab
, vol.5
, pp. 375-388
-
-
Varma, M.V.1
Khandavilli, S.2
Ashokraj, Y.3
Jain, A.4
Dhanikula, A.5
Sood, A.6
Thomas, N.S.7
Pillai, O.8
Sharma, P.9
Gandhi, R.10
-
191
-
-
84866708911
-
Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions
-
Varma MV, Lai Y, Feng B, Litchfield J, Goosen TC, and Bergman A (2012c) Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions. Pharm Res 29:2860-2873.
-
(2012)
Pharm Res
, vol.29
, pp. 2860-2873
-
-
Varma, M.V.1
Lai, Y.2
Feng, B.3
Litchfield, J.4
Goosen, T.C.5
Bergman, A.6
-
192
-
-
84877786965
-
Response to the comment on the article "physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions"
-
Varma MV, Lai Y, Feng B, Litchfield J, Goosen TC, and Bergman A (2013a) Response to the comment on the article "physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions". Pharm Res 30:1469-1470.
-
(2013)
Pharm Res
, vol.30
, pp. 1469-1470
-
-
Varma, M.V.1
Lai, Y.2
Feng, B.3
Litchfield, J.4
Goosen, T.C.5
Bergman, A.6
-
193
-
-
84876483882
-
Mechanistic modeling to predict the transporter- and enzyme-mediated drug-drug interactions of repaglinide
-
Varma MV, Lai Y, Kimoto E, Goosen TC, El-Kattan AF, and Kumar V (2013b) Mechanistic modeling to predict the transporter- and enzyme-mediated drug-drug interactions of repaglinide. Pharm Res 30:1188-1199.
-
(2013)
Pharm Res
, vol.30
, pp. 1188-1199
-
-
Varma, M.V.1
Lai, Y.2
Kimoto, E.3
Goosen, T.C.4
El-Kattan, A.F.5
Kumar, V.6
-
194
-
-
84876752739
-
Quantitative prediction of repaglinide-rifampicin complex drug interactions using dynamic and static mechanistic models: Delineating differential CYP3A4 induction and OATP1B1 inhibition potential of rifampicin
-
Varma MV, Lin J, Bi YA, Rotter CJ, Fahmi OA, Lam JL, El-Kattan AF, Goosen TC, and Lai Y (2013c) Quantitative prediction of repaglinide-rifampicin complex drug interactions using dynamic and static mechanistic models: delineating differential CYP3A4 induction and OATP1B1 inhibition potential of rifampicin. Drug Metab Dispos 41:966-974.
-
(2013)
Drug Metab Dispos
, vol.41
, pp. 966-974
-
-
Varma, M.V.1
Lin, J.2
Bi, Y.A.3
Rotter, C.J.4
Fahmi, O.A.5
Lam, J.L.6
El-Kattan, A.F.7
Goosen, T.C.8
Lai, Y.9
-
195
-
-
77249122159
-
Physicochemical space for optimum oral bioavailability: Contribution of human intestinal absorption and first-pass elimination
-
Varma MV, Obach RS, Rotter C, Miller HR, Chang G, Steyn SJ, El-Kattan A, and Troutman MD (2010) Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. J Med Chem 53:1098-1108.
-
(2010)
J Med Chem
, vol.53
, pp. 1098-1108
-
-
Varma, M.V.1
Obach, R.S.2
Rotter, C.3
Miller, H.R.4
Chang, G.5
Steyn, S.J.6
El-Kattan, A.7
Troutman, M.D.8
-
196
-
-
20744446221
-
Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability
-
Varma MV and Panchagnula R (2005) Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability. J Pharm Sci 94:1694-1704.
-
(2005)
J Pharm Sci
, vol.94
, pp. 1694-1704
-
-
Varma, M.V.1
Panchagnula, R.2
-
197
-
-
79961089466
-
pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1
-
Varma MV, Rotter CJ, Chupka J, Whalen KM, Duignan DB, Feng B, Litchfield J, Goosen TC, and El-Kattan AF (2011) pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1. Mol Pharm 8:1303-1313.
-
(2011)
Mol Pharm
, vol.8
, pp. 1303-1313
-
-
Varma, M.V.1
Rotter, C.J.2
Chupka, J.3
Whalen, K.M.4
Duignan, D.B.5
Feng, B.6
Litchfield, J.7
Goosen, T.C.8
El-Kattan, A.F.9
-
198
-
-
0033674502
-
Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: Ratios of accessory proteins as sources of discrepancies between the approaches
-
Venkatakrishnan K, von Moltke LL, Court MH, Harmatz JS, Crespi CL, and Greenblatt DJ (2000) Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches. Drug Metab Dispos 28:1493-1504.
-
(2000)
Drug Metab Dispos
, vol.28
, pp. 1493-1504
-
-
Venkatakrishnan, K.1
Von Moltke, L.L.2
Court, M.H.3
Harmatz, J.S.4
Crespi, C.L.5
Greenblatt, D.J.6
-
199
-
-
1542376174
-
Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: A comparative analysis in paired tissue specimens
-
von Richter O, Burk O, Fromm MF, Thon KP, Eichelbaum M, and Kivistö KT (2004) Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens. Clin Pharmacol Ther 75:172-183.
-
(2004)
Clin Pharmacol Ther
, vol.75
, pp. 172-183
-
-
Von Richter, O.1
Burk, O.2
Fromm, M.F.3
Thon, K.P.4
Eichelbaum, M.5
Kivistö, K.T.6
-
200
-
-
0035290059
-
Active secretion and enterocytic drug metabolism barriers to drug absorption
-
Wacher VJ, Salphati L, and Benet LZ (2001) Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv Drug Deliv Rev 46:89-102.
-
(2001)
Adv Drug Deliv Rev
, vol.46
, pp. 89-102
-
-
Wacher, V.J.1
Salphati, L.2
Benet, L.Z.3
-
201
-
-
3042648079
-
Prediction of human pharmacokinetic profile in animal scale up based on normalizing time course profiles
-
Wajima T, Yano Y, Fukumura K, and Oguma T (2004) Prediction of human pharmacokinetic profile in animal scale up based on normalizing time course profiles. J Pharm Sci 93:1890-1900.
-
(2004)
J Pharm Sci
, vol.93
, pp. 1890-1900
-
-
Wajima, T.1
Yano, Y.2
Fukumura, K.3
Oguma, T.4
-
202
-
-
79951931440
-
Validation of isolated metabolites from drug metabolism studies as analytical standards by quantitative NMR
-
Walker GS, Ryder TF, Sharma R, Smith EB, and Freund A (2011) Validation of isolated metabolites from drug metabolism studies as analytical standards by quantitative NMR. Drug Metab Dispos 39:433-440.
-
(2011)
Drug Metab Dispos
, vol.39
, pp. 433-440
-
-
Walker, G.S.1
Ryder, T.F.2
Sharma, R.3
Smith, E.B.4
Freund, A.5
-
203
-
-
77953787344
-
Confidence assessment of the Simcyp time-based approach and a static mathematical model in predicting clinical drug-drug interactions for mechanism-based CYP3A inhibitors
-
Wang YH (2010) Confidence assessment of the Simcyp time-based approach and a static mathematical model in predicting clinical drug-drug interactions for mechanism-based CYP3A inhibitors. Drug Metab Dispos 38:1094-1104.
-
(2010)
Drug Metab Dispos
, vol.38
, pp. 1094-1104
-
-
Wang, Y.H.1
-
204
-
-
2442691625
-
A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time
-
Ward KW and Smith BR (2004) A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time. Drug Metab Dispos 32:612-619.
-
(2004)
Drug Metab Dispos
, vol.32
, pp. 612-619
-
-
Ward, K.W.1
Smith, B.R.2
-
205
-
-
59649130318
-
Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans
-
Watanabe T, Kusuhara H, Maeda K, Shitara Y, and Sugiyama Y (2009a) Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans. J Pharmacol Exp Ther 328:652-662.
-
(2009)
J Pharmacol Exp Ther
, vol.328
, pp. 652-662
-
-
Watanabe, T.1
Kusuhara, H.2
Maeda, K.3
Shitara, Y.4
Sugiyama, Y.5
-
206
-
-
79951768576
-
Application of physiologically based pharmacokinetic modeling and clearance concept to drugs showing transporter-mediated distribution and clearance in humans
-
Watanabe T, Kusuhara H, and Sugiyama Y (2010) Application of physiologically based pharmacokinetic modeling and clearance concept to drugs showing transporter-mediated distribution and clearance in humans. J Pharmacokinet Pharmacodyn 37:575-590.
-
(2010)
J Pharmacokinet Pharmacodyn
, vol.37
, pp. 575-590
-
-
Watanabe, T.1
Kusuhara, H.2
Sugiyama, Y.3
-
207
-
-
67649406103
-
Prediction of the hepatic and renal clearance of transporter substrates in rats using in vitro uptake experiments
-
Watanabe T, Maeda K, Kondo T, Nakayama H, Horita S, Kusuhara H, and Sugiyama Y (2009b) Prediction of the hepatic and renal clearance of transporter substrates in rats using in vitro uptake experiments. Drug Metab Dispos 37:1471-1479.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 1471-1479
-
-
Watanabe, T.1
Maeda, K.2
Kondo, T.3
Nakayama, H.4
Horita, S.5
Kusuhara, H.6
Sugiyama, Y.7
-
208
-
-
77953777481
-
Use of the Øie-Tozer model in understanding mechanisms and determinants of drug distribution
-
Waters NJ and Lombardo F (2010) Use of the Øie-Tozer model in understanding mechanisms and determinants of drug distribution. Drug Metab Dispos 38:1159-1165.
-
(2010)
Drug Metab Dispos
, vol.38
, pp. 1159-1165
-
-
Waters, N.J.1
Lombardo, F.2
-
209
-
-
35648929358
-
In vitro-in vivo extrapolation of hepatic clearance involving active uptake: Theoretical and experimental aspects
-
Webborn PJ, Parker AJ, Denton RL, and Riley RJ (2007) In vitro-in vivo extrapolation of hepatic clearance involving active uptake: theoretical and experimental aspects. Xenobiotica 37:1090-1109.
-
(2007)
Xenobiotica
, vol.37
, pp. 1090-1109
-
-
Webborn, P.J.1
Parker, A.J.2
Denton, R.L.3
Riley, R.J.4
-
210
-
-
0016566218
-
Commentary: A physiological approach to hepatic drug clearance
-
Wilkinson GR and Shand DG (1975) Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18:377-390.
-
(1975)
Clin Pharmacol Ther
, vol.18
, pp. 377-390
-
-
Wilkinson, G.R.1
Shand, D.G.2
-
211
-
-
6944221357
-
Drug-drug interactions for UDP-glucuronosyltransferase substrates: A pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios
-
Williams JA, Hyland R, Jones BC, Smith DA, Hurst S, Goosen TC, Peterkin V, Koup JR, and Ball SE (2004) Drug-drug interactions for UDP- glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab Dispos 32:1201-1208.
-
(2004)
Drug Metab Dispos
, vol.32
, pp. 1201-1208
-
-
Williams, J.A.1
Hyland, R.2
Jones, B.C.3
Smith, D.A.4
Hurst, S.5
Goosen, T.C.6
Peterkin, V.7
Koup, J.R.8
Ball, S.E.9
-
212
-
-
17644380257
-
Predicting drug disposition via application of BCS: Transport/ absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system
-
Wu CY and Benet LZ (2005) Predicting drug disposition via application of BCS: transport/ absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 22:11-23.
-
(2005)
Pharm Res
, vol.22
, pp. 11-23
-
-
Wu, C.Y.1
Benet, L.Z.2
-
213
-
-
80053161024
-
Kinetic characterization of rat hepatic uptake of 16 actively transported drugs
-
Yabe Y, Galetin A, and Houston JB (2011) Kinetic characterization of rat hepatic uptake of 16 actively transported drugs. Drug Metab Dispos 39:1808-1814.
-
(2011)
Drug Metab Dispos
, vol.39
, pp. 1808-1814
-
-
Yabe, Y.1
Galetin, A.2
Houston, J.B.3
-
214
-
-
0029782268
-
Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats
-
Yamazaki M, Kobayashi K, and Sugiyama Y (1996) Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats. Biopharm Drug Dispos 17:607-621.
-
(1996)
Biopharm Drug Dispos
, vol.17
, pp. 607-621
-
-
Yamazaki, M.1
Kobayashi, K.2
Sugiyama, Y.3
-
215
-
-
35348895572
-
Prediction of intestinal first-pass drug metabolism
-
Yang J, Jamei M, Yeo KR, Tucker GT, and Rostami-Hodjegan A (2007a) Prediction of intestinal first-pass drug metabolism. Curr Drug Metab 8:676-684.
-
(2007)
Curr Drug Metab
, vol.8
, pp. 676-684
-
-
Yang, J.1
Jamei, M.2
Yeo, K.R.3
Tucker, G.T.4
Rostami-Hodjegan, A.5
-
216
-
-
34249274907
-
Theoretical assessment of a new experimental protocol for determining kinetic values describing mechanism (time)-based enzyme inhibition
-
Yang J, Jamei M, Yeo KR, Tucker GT, and Rostami-Hodjegan A (2007b) Theoretical assessment of a new experimental protocol for determining kinetic values describing mechanism (time)-based enzyme inhibition. Eur J Pharm Sci 31:232-241.
-
(2007)
Eur J Pharm Sci
, vol.31
, pp. 232-241
-
-
Yang, J.1
Jamei, M.2
Yeo, K.R.3
Tucker, G.T.4
Rostami-Hodjegan, A.5
-
217
-
-
24644441043
-
Kinetic values for mechanism-based enzyme inhibition: Assessing the bias introduced by the conventional experimental protocol
-
Yang J, Jamei M, Yeo KR, Tucker GT, and Rostami-Hodjegan A (2005) Kinetic values for mechanism-based enzyme inhibition: assessing the bias introduced by the conventional experimental protocol. Eur J Pharm Sci 26:334-340.
-
(2005)
Eur J Pharm Sci
, vol.26
, pp. 334-340
-
-
Yang, J.1
Jamei, M.2
Yeo, K.R.3
Tucker, G.T.4
Rostami-Hodjegan, A.5
-
218
-
-
73349114878
-
Prediction of biliary excretion in rats and humans using molecular weight and quantitative structure-pharmacokinetic relationships
-
Yang X, Gandhi YA, Duignan DB, and Morris ME (2009) Prediction of biliary excretion in rats and humans using molecular weight and quantitative structure-pharmacokinetic relationships. AAPS J 11:511-525.
-
(2009)
AAPS J
, vol.11
, pp. 511-525
-
-
Yang, X.1
Gandhi, Y.A.2
Duignan, D.B.3
Morris, M.E.4
-
219
-
-
84869108969
-
Statistical methods for analysis of time-dependent inhibition of cytochrome p450 enzymes
-
Yates P, Eng H, Di L, and Obach RS (2012) Statistical methods for analysis of time-dependent inhibition of cytochrome p450 enzymes. Drug Metab Dispos 40:2289-2296.
-
(2012)
Drug Metab Dispos
, vol.40
, pp. 2289-2296
-
-
Yates, P.1
Eng, H.2
Di, L.3
Obach, R.S.4
-
220
-
-
84861349018
-
Transporter-mediated drug - Drug interactions involving OATP substrates: Predictions based on in vitro inhibition studies
-
Yoshida K, Maeda K, and Sugiyama Y (2012) Transporter-mediated drug - drug interactions involving OATP substrates: predictions based on in vitro inhibition studies. Clin Pharmacol Ther 91:1053-1064.
-
(2012)
Clin Pharmacol Ther
, vol.91
, pp. 1053-1064
-
-
Yoshida, K.1
Maeda, K.2
Sugiyama, Y.3
-
221
-
-
0032888376
-
A compartmental absorption and transit model for estimating oral drug absorption
-
Yu LX and Amidon GL (1999) A compartmental absorption and transit model for estimating oral drug absorption. Int J Pharm 186:119-125.
-
(1999)
Int J Pharm
, vol.186
, pp. 119-125
-
-
Yu, L.X.1
Amidon, G.L.2
-
222
-
-
0035997323
-
Biopharmaceutics classification system: The scientific basis for biowaiver extensions
-
Yu LX, Amidon GL, Polli JE, Zhao H, Mehta MU, Conner DP, Shah VP, Lesko LJ, Chen ML, and Lee VH, et al. (2002) Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm Res 19:921-925.
-
(2002)
Pharm Res
, vol.19
, pp. 921-925
-
-
Yu, L.X.1
Amidon, G.L.2
Polli, J.E.3
Zhao, H.4
Mehta, M.U.5
Conner, D.P.6
Shah, V.P.7
Lesko, L.J.8
Chen, M.L.9
Lee, V.H.10
-
223
-
-
33846674113
-
Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: A new look at an old drug
-
Zhang H, Cui D, Wang B, Han YH, Balimane P, Yang Z, Sinz M, and Rodrigues AD (2007) Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug. Clin Pharmacokinet 46:133-157.
-
(2007)
Clin Pharmacokinet
, vol.46
, pp. 133-157
-
-
Zhang, H.1
Cui, D.2
Wang, B.3
Han, Y.H.4
Balimane, P.5
Yang, Z.6
Sinz, M.7
Rodrigues, A.D.8
-
224
-
-
84862634533
-
Best practice in the use of physiologically based pharmacokinetic modeling and simulation to address clinical pharmacology regulatory questions
-
Zhao P, Rowland M, and Huang SM (2012) Best practice in the use of physiologically based pharmacokinetic modeling and simulation to address clinical pharmacology regulatory questions. Clin Pharmacol Ther 92:17-20.
-
(2012)
Clin Pharmacol Ther
, vol.92
, pp. 17-20
-
-
Zhao, P.1
Rowland, M.2
Huang, S.M.3
-
225
-
-
78951482203
-
Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review
-
Zhao P, Zhang L, Grillo JA, Liu Q, Bullock JM, Moon YJ, Song P, Brar SS, Madabushi R, and Wu TC, et al. (2011) Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review. Clin Pharmacol Ther 89:259-267.
-
(2011)
Clin Pharmacol Ther
, vol.89
, pp. 259-267
-
-
Zhao, P.1
Zhang, L.2
Grillo, J.A.3
Liu, Q.4
Bullock, J.M.5
Moon, Y.J.6
Song, P.7
Brar, S.S.8
Madabushi, R.9
Wu, T.C.10
-
226
-
-
77954897164
-
In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase
-
Zientek M, Jiang Y, Youdim K, and Obach RS (2010) In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase. Drug Metab Dispos 38:1322-1327.
-
(2010)
Drug Metab Dispos
, vol.38
, pp. 1322-1327
-
-
Zientek, M.1
Jiang, Y.2
Youdim, K.3
Obach, R.S.4
-
227
-
-
84860138724
-
Prediction of volume of distribution at steady state in humans: Comparison of different approaches
-
Zou P, Zheng N, Yang Y, Yu LX, and Sun D (2012) Prediction of volume of distribution at steady state in humans: comparison of different approaches. Expert Opin Drug Metab Toxicol 8:855-872.
-
(2012)
Expert Opin Drug Metab Toxicol
, vol.8
, pp. 855-872
-
-
Zou, P.1
Zheng, N.2
Yang, Y.3
Yu, L.X.4
Sun, D.5
|